OBO_ID (LABEL):	UBERON_0002046 (thyroid gland)

ARTICLE	ARTICLE DATE	SENTENCE NUM	SENTENCE	IGNORANCE CATEGORIES	NUM IGNORANCE CATEGORIES	OBO ID (LABEL)
PMC1247491	8/2004	S1-PMC1247491	['the fetus is wholly dependent on the maternal Thyroid during the first 10–20 weeks of Gestation.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 46, 'thyroid'), ('GO_0007565', 'female pregnancy', 86, 'gestation')]
PMC1247491	8/2004	S4-PMC1247491	['these and other topics were discussed by scientists at a january 2004 symposium cosponsored by the centers for disease control and prevention, the national center on Birth defects and developmental disabilities, and the american Thyroid association (ata).']	N/A	N/A	[('GO_0007567', 'parturition', 166, 'Birth'), ('UBERON_0002046', 'thyroid gland', 229, 'Thyroid')]
PMC1247491	8/2004	S5-PMC1247491	['early maternal Thyroidal insufficiency, or emti, is a failure of the maternal Thyroid to provide an adequate supply of T4In early Pregnancy.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 15, 'thyroidal'), ('UBERON_0002046', 'thyroid gland', 78, 'thyroid'), ('PR_000016879', 'TYRO protein tyrosine kinase-binding protein', 119, 'T4in'), ('GO_0007565', 'female pregnancy', 130, 'pregnancy')]
PMC1247491	8/2004	S18-PMC1247491	['an experimental group will have t4and the complementary Thyroid-stimulating hormone (tsh) measured and thryoxine treatment applied if necessary, while the control mothers will remain untested until after their babies are Delivered.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 56, 'thyroid'), ('GO_0007567', 'parturition', 221, 'delivered')]
PMC1764147	12/2006	S0-PMC1764147	['Urinary Perchlorate and Thyroid Hormone levels in Adolescent and Adult men and women living in the united states\n\nabstract\n\nbackground\nperchlorate is commonly found in the environment and known to inhibit Thyroid function at high doses.']	N/A	N/A	[('UBERON_0001088', 'urine', 0, 'Urinary'), ('CHEBI_49706', 'perchlorate', 8, 'Perchlorate'), ('CHEBI_60311', 'thyroid hormone', 24, 'Thyroid Hormone'), ('GO_0007525', 'somatic muscle development', 50, 'Adolescent'), ('UBERON_0007023', 'adult organism', 65, 'Adult'), ('UBERON_0002046', 'thyroid gland', 205, 'thyroid')]
PMC1764147	12/2006	S76-PMC1764147	['of these 1,226 women, 91 were excluded from analysis because they reported a history of Thyroid disease or current use of Thyroid Medications, leaving 1,135 women.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 88, 'thyroid'), ('UBERON_0002046', 'thyroid gland', 122, 'thyroid'), ('CHEBI_25441', 'mycothiols', 130, 'medications')]
PMC1764147	12/2006	S96-PMC1764147	['Serum Albumin accounts for 15–20% of t4binding, with Thyroid Binding Protein and Prealbumin (not measured in nhanes) accounting for the remaining percentage (robbins 2000).']	N/A	N/A	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('PR_000005908', 'alpha-crystallin B chain', 6, 'albumin'), ('PR_000016588', 'nucleoprotein TPR', 53, 'thyroid binding protein'), ('UBERON_0002046', 'thyroid gland', 53, 'thyroid'), ('PR_000005267', 'cyclin-dependent kinase 9', 81, 'prealbumin')]
PMC1764147	12/2006	S101-PMC1764147	['as noted above, women taking medication containing Thyroid hormone (e.g., Levothyroxine) or Antithyroid Drugs (e.g., Methimazole or Propylthiouracil) were excluded.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 51, 'thyroid'), ('CHEBI_6437', 'levetiracetam', 74, 'levothyroxine'), ('CHEBI_35820', 'antiprotozoal drug', 92, 'antithyroid drugs'), ('CHEBI_50673', 'methimazole', 117, 'methimazole'), ('CHEBI_8474', 'propane-2-thiol', 132, 'propylthiouracil')]
PMC1764147	12/2006	S193-PMC1764147	['both Estrogen use and Pregnancy raise Estrogen levels, increase Thyroid binding proteins, and increase Serum t4concentrations (glinoer 1997).']	N/A	N/A	[('CHEBI_50114', 'estrogen', 5, 'estrogen'), ('GO_0007565', 'female pregnancy', 22, 'pregnancy'), ('CHEBI_50114', 'estrogen', 38, 'estrogen'), ('UBERON_0002046', 'thyroid gland', 64, 'thyroid'), ('UBERON_0001977', 'blood serum', 103, 'serum')]
PMC2685772	4/2009	S43-PMC2685772	['the 226 women were healthy and had no history of hypertension, diabetes or Thyroid problems.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 75, 'thyroid')]
PMC2704503	6/2007	S38-PMC2704503	['additional studies included: westergren Erythrocyte sedimentation rate (esr) = 62 mm/hour (hr); normal Thyroid function panel; protein c = 175 (normal range: 60–140); activated partial thromboplastin time = 23.7 seconds, and an equivocal lyme screen.']	N/A	N/A	[('CL_0000232', 'erythrocyte', 40, 'erythrocyte'), ('UBERON_0002046', 'thyroid gland', 103, 'thyroid')]
PMC2777012	4/2009	S0-PMC2777012	['goiter and multiple Food allergies\n\nabstract\nsevere Iodine deficiency results in impaired Thyroid Hormone Synthesis and Thyroid enlargement.']	N/A	N/A	[('CHEBI_33290', 'food', 20, 'Food'), ('CHEBI_24859', 'iodine atom', 52, 'iodine'), ('CHEBI_9437', 'temoporfin', 90, 'thyroid'), ('GO_0007565', 'female pregnancy', 90, 'thyroid'), ('UBERON_0002046', 'thyroid gland', 90, 'thyroid'), ('GO_0042446', 'hormone biosynthetic process', 98, 'hormone synthesis'), ('UBERON_0002046', 'thyroid gland', 120, 'thyroid')]
PMC2777012	4/2009	S30-PMC2777012	['he had a significantly enlarged smooth Thyroid Gland.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 39, 'thyroid gland')]
PMC2777012	4/2009	S31-PMC2777012	['a Thyroid ultrasound showed Thyromegaly without underlying mass.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 2, 'thyroid'), ('UBERON_0001818', 'tarsal gland', 28, 'thyromegaly')]
PMC2777012	4/2009	S34-PMC2777012	['his Thyroid function was as follows: free Triiodothyronine (free T3) 476 pg/dl (normal 335–480), free tetraiodothyronine (free T4) 0.2 ng/dl (normal 0.8–2.0), total tetraiodothyronine (total t4) 1.6 μ g/dl (normal 4.5–10.0), and thyrotropin (tsh) 16.5 μ iu/ml (normal 0.50–4.50).']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 4, 'thyroid'), ('CHEBI_26982', 'threo-3-methylmalic acid', 42, 'triiodothyronine'), ('CHEBI_37972', 'phosphorus-32 atom', 65, 'T3'), ('CHEBI_37972', 'phosphorus-32 atom', 127, 'T4')]
PMC2777012	4/2009	S35-PMC2777012	['his Thyroid Antibodies were negative.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 4, 'thyroid'), ('GO_0042571', 'immunoglobulin complex, circulating', 12, 'antibodies')]
PMC2777012	4/2009	S43-PMC2777012	['after three months of supplementation, his Thyroid function tests have normalized and his goiter has decreased dramatically in size to almost normal.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 43, 'thyroid')]
PMC2798111	12/2010	S32-PMC2798111	['exclusion criteria included preexisting type i or type ii diabetes, hypertension, Parathyroid disease, and uncontrolled Thyroid disease.']	N/A	N/A	[('UBERON_0001132', 'parathyroid gland', 82, 'parathyroid'), ('UBERON_0002046', 'thyroid gland', 120, 'thyroid')]
PMC2831965	1/2010	S0-PMC2831965	['basis of the massachusetts reference dose and drinking Water standard for Perchlorate\n\nabstract\n\nobjective\nperchlorate inhibits the Uptake Of Iodide in the Thyroid.']	N/A	N/A	[('CHEBI_15377', 'water', 55, 'Water'), ('CHEBI_49706', 'perchlorate', 74, 'Perchlorate'), ('GO_0043652', 'engulfment of apoptotic cell', 132, 'uptake of'), ('CHEBI_16382', 'iodide', 142, 'iodide'), ('UBERON_0002046', 'thyroid gland', 156, 'thyroid')]
PMC2831965	1/2010	S32-PMC2831965	['key studies, data sources, and Toxicological considerations for Perchlorate risk assessment\n\ntoxicokinetics\ningested Perchlorate is extensively absorbed from the Gastrointestinal System and accumulates in the Thyroid (ma dep 2006;nrc 2005;u.s. epa 2002c).']	N/A	N/A	[('CHEBI_63634', 'valdecoxib', 31, 'Toxicological'), ('CHEBI_49706', 'perchlorate', 64, 'Perchlorate'), ('CHEBI_49706', 'perchlorate', 117, 'perchlorate'), ('UBERON_0005409', 'alimentary part of gastrointestinal system', 162, 'gastrointestinal system'), ('UBERON_0002046', 'thyroid gland', 209, 'thyroid')]
PMC2831965	1/2010	S49-PMC2831965	['preferential secretion of Perchlorate over Iodide into Breast Milk would reduce the nursing infant’s Iodide Intake and exacerbate neonatal Thyroid sensitivity to Perchlorate in the Milk.']	N/A	N/A	[('CHEBI_49706', 'perchlorate', 26, 'perchlorate'), ('CHEBI_16382', 'iodide', 43, 'iodide'), ('UBERON_0000310', 'breast', 55, 'breast'), ('UBERON_0001913', 'milk', 62, 'milk'), ('CHEBI_16382', 'iodide', 101, 'iodide'), ('GO_0007631', 'feeding behavior', 108, 'intake'), ('UBERON_0002046', 'thyroid gland', 139, 'thyroid'), ('CHEBI_49706', 'perchlorate', 162, 'perchlorate'), ('UBERON_0001913', 'milk', 181, 'milk')]
PMC2831965	1/2010	S51-PMC2831965	['Iodide Transport is mediated by the Sodium (Na)–Iodide (I) symporter (nis), an integral Membrane protein present in the Thyroid, the Mammary Gland, and other Tissues (vieja et al.']	N/A	N/A	[('CHEBI_5859', 'Icacine', 0, 'Iodide'), ('GO_0042074', 'cell migration involved in gastrulation', 0, 'Iodide transport'), ('CHEBI_52632', 'potassium-39 atom', 36, 'sodium'), ('CHEBI_31894', 'Nandrolone furylpropionate', 44, 'Na)–iodide'), ('CHEBI_51686', 'haematoxylin', 56, 'I'), ('GO_0016020', 'membrane', 88, 'membrane'), ('UBERON_0002046', 'thyroid gland', 120, 'thyroid'), ('UBERON_0001911', 'mammary gland', 133, 'mammary gland'), ('UBERON_0000479', 'tissue', 158, 'tissues')]
PMC2831965	1/2010	S74-PMC2831965	['decreases in the Serum levels of Thyroid hormones trigger a feedback system involving the Hypothalamus–Pituitary–Thyroid axis (nrc 2005).']	N/A	N/A	[('UBERON_0001977', 'blood serum', 17, 'serum'), ('CHEBI_9437', 'temoporfin', 33, 'thyroid'), ('UBERON_0002046', 'thyroid gland', 33, 'thyroid'), ('UBERON_0001898', 'hypothalamus', 90, 'hypothalamus'), ('UBERON_0002109', 'pair of nares', 103, 'pituitary'), ('UBERON_0002046', 'thyroid gland', 113, 'thyroid')]
PMC2831965	1/2010	S75-PMC2831965	['the Hypothalamus uses thyrotropin-releasing hormone (trh) to Control the Pituitary Gland, which in turn Controls the Thyroid through Thyroid-stimulating hormone (tsh).']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 4, 'hypothalamus'), ('GO_0065007', 'biological regulation', 61, 'control'), ('UBERON_0000007', 'pituitary gland', 73, 'pituitary gland'), ('GO_0065007', 'biological regulation', 104, 'controls'), ('UBERON_0002046', 'thyroid gland', 117, 'thyroid'), ('UBERON_0002046', 'thyroid gland', 133, 'thyroid')]
PMC2831965	1/2010	S86-PMC2831965	['during the fetal and neonatal periods, the Thyroid Gland is incompletely developed, increasing susceptibility to Toxicants that disrupt Thyroid function.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 43, 'thyroid gland'), ('CHEBI_35704', 'N(2)-acetyl-L-lysine', 113, 'toxicants'), ('UBERON_0002046', 'thyroid gland', 136, 'thyroid')]
PMC2831965	1/2010	S89-PMC2831965	['1999), as well as Thyroid Hormone turnover rates two to three times faster than in Adults (van den hove et al.']	N/A	N/A	[('CHEBI_60311', 'thyroid hormone', 18, 'thyroid hormone'), ('UBERON_0002046', 'thyroid gland', 18, 'thyroid'), ('UBERON_0007023', 'adult organism', 83, 'adults')]
PMC2831965	1/2010	S170-PMC2831965	['in the most sensitive species, changes in Thyroid hormones were observed at the lowest dose tested, 0.0085 mg/kg/day (u.s. epa 2002c).']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 42, 'thyroid')]
PMC3112517	5/2011	S76-PMC3112517	['radioactive Iodine scan or stimulated thyroglobulin (tg) estimation through either Thyroid Hormone withdrawal or recombinant Tsh (thyrogen) is not justifiable in Pregnancy.']	N/A	N/A	[('CHEBI_24859', 'iodine atom', 12, 'iodine'), ('CHEBI_60311', 'thyroid hormone', 83, 'thyroid hormone'), ('UBERON_0002046', 'thyroid gland', 83, 'thyroid'), ('CHEBI_17855', 'triglyceride', 125, 'TSH'), ('GO_0007565', 'female pregnancy', 162, 'pregnancy')]
PMC3120183	7/2011	S30-PMC3120183	['exclusion criteria included: age <18 years; multiple Gestation; diagnosis of diabetic retinopathy; high-risk Pregnancy (i.e., Drug or alcohol abuse, chronic health problems, or Pregnancy complications); Thyroid diseases diagnosed in the last 30 days; and non-english speaker.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 53, 'gestation'), ('GO_0007565', 'female pregnancy', 109, 'pregnancy'), ('CHEBI_23888', 'drug', 126, 'drug'), ('GO_0007565', 'female pregnancy', 177, 'pregnancy'), ('UBERON_0002046', 'thyroid gland', 203, 'thyroid')]
PMC3134395	6/2011	S8-PMC3134395	['Uptake Of Iodine By the Thyroid varies with Intake.']	N/A	N/A	[('GO_0006277', 'DNA amplification', 0, 'Uptake of iodine by ... thyroid'), ('CHEBI_24859', 'iodine atom', 10, 'iodine'), ('UBERON_0002046', 'thyroid gland', 24, 'thyroid'), ('GO_0007631', 'feeding behavior', 44, 'intake')]
PMC3134395	6/2011	S9-PMC3134395	['when Iodine Intake is sufficient, the proportion cleared from the Blood by the Thyroid ranges from 10% to 80% of absorbed Iodine [1].']	N/A	N/A	[('CHEBI_24859', 'iodine atom', 5, 'iodine'), ('GO_0007631', 'feeding behavior', 12, 'intake'), ('UBERON_0000178', 'blood', 66, 'blood'), ('UBERON_0002046', 'thyroid gland', 79, 'thyroid'), ('CHEBI_24859', 'iodine atom', 122, 'iodine')]
PMC3134395	6/2011	S10-PMC3134395	['the active Transport Of Iodine From the Blood Into the Thyroid is Regulated by Thyroid-Stimulating Hormone (Tsh) from the Pituitary Gland and by the concentration of Iodine in the Blood.']	N/A	N/A	[('GO_0001658', 'branching involved in ureteric bud morphogenesis', 11, 'transport of iodine from ... blood into ... thyroid'), ('CHEBI_24859', 'iodine atom', 24, 'iodine'), ('UBERON_0000178', 'blood', 40, 'blood'), ('UBERON_0002046', 'thyroid gland', 55, 'thyroid'), ('GO_0065007', 'biological regulation', 66, 'regulated'), ('PR_000016293', 'protein-glutamine gamma-glutamyltransferase 2', 79, 'thyroid-stimulating hormone'), ('UBERON_0002046', 'thyroid gland', 79, 'thyroid'), ('PR_000016711', 'TSC22 domain family protein 1', 108, 'TSH'), ('UBERON_0000007', 'pituitary gland', 122, 'pituitary gland'), ('CHEBI_24859', 'iodine atom', 166, 'iodine'), ('UBERON_0000178', 'blood', 180, 'blood')]
PMC3134395	6/2011	S12-PMC3134395	['Iodine entering the Thyroid is oxidized to form “active” Iodine which then iodinates tyrosine to form monoiodotyrosine (mit) and diiodotyrosine (dit).']	N/A	N/A	[('CHEBI_31719', 'ipriflavone', 0, 'Iodine'), ('UBERON_0002046', 'thyroid gland', 20, 'thyroid'), ('CHEBI_24859', 'iodine atom', 57, 'iodine')]
PMC3134395	6/2011	S13-PMC3134395	['the coupling of mit and dit through an Ether linkage generates the Thyroid hormones, thyroxine (t4) and Triiodothyronine (t3), which are then cleaved from thyroglobulin, pass through the golgi, and are Secreted into the Peripheral Circulation.']	N/A	N/A	[('CHEBI_25698', 'ether', 39, 'ether'), ('UBERON_0002046', 'thyroid gland', 67, 'thyroid'), ('CHEBI_26982', 'threo-3-methylmalic acid', 104, 'triiodothyronine'), ('GO_0046903', 'secretion', 202, 'secreted'), ('UBERON_0002409', 'pericardial fluid', 220, 'peripheral circulation')]
PMC3134395	6/2011	S14-PMC3134395	['all of the steps directed toward the Generation Of T4 and T3 are stimulated by Thyroid peroxidase (Tpo) (figure 1).']	N/A	N/A	[('GO_0007281', 'germ cell development', 37, 'generation of T4'), ('PR_000016190', 'trichohyalin-like protein 1', 51, 'T4'), ('PR_000016190', 'trichohyalin-like protein 1', 58, 'T3'), ('UBERON_0002046', 'thyroid gland', 79, 'thyroid'), ('PR_000016585', 'tripeptidyl-peptidase 1', 99, 'TPO')]
PMC3134395	6/2011	S16-PMC3134395	['peripheral deiodinases further Metabolize Thyroid Hormone and add to circulating Iodine (figure 2).']	N/A	N/A	[('GO_0008152', 'metabolic process', 31, 'metabolize'), ('CHEBI_60311', 'thyroid hormone', 42, 'thyroid hormone'), ('UBERON_0002046', 'thyroid gland', 42, 'thyroid'), ('CHEBI_24859', 'iodine atom', 81, 'iodine')]
PMC3134395	6/2011	S18-PMC3134395	['the Iodine that is cleaved from t4 and t3 re-enters the circulation where it is available for reutilization by the Thyroid.']	N/A	N/A	[('CHEBI_24859', 'iodine atom', 4, 'iodine'), ('UBERON_0002046', 'thyroid gland', 115, 'thyroid')]
PMC3134395	6/2011	S21-PMC3134395	['physiologic changes in Pregnancy\nPregnancy induces several major changes to Thyroid physiology.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 23, 'Pregnancy'), ('GO_0007565', 'female pregnancy', 33, 'Pregnancy'), ('UBERON_0002046', 'thyroid gland', 76, 'thyroid')]
PMC3134395	6/2011	S22-PMC3134395	['the first is increased demand on the maternal Thyroid Gland.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 46, 'thyroid gland')]
PMC3134395	6/2011	S26-PMC3134395	['additionally, in early Gestation, the Thyroid is stimulated not only by tsh but by the Alpha Subunit Of Human Chorionic Gonadotropin (Hcg), which also binds to and stimulates the tsh receptor [3].']	N/A	N/A	[('GO_0007565', 'female pregnancy', 23, 'gestation'), ('UBERON_0002046', 'thyroid gland', 38, 'thyroid'), ('PR_000003900', 'aldo-keto reductase family 1 member A1', 87, 'alpha subunit of human chorionic gonadotropin'), ('NCBITaxon_9606', 'Homo sapiens', 104, 'human'), ('UBERON_0003124', 'chorion', 110, 'chorionic'), ('PR_000006060', 'CWF19-like protein 1', 134, 'hCG')]
PMC3134395	6/2011	S38-PMC3134395	['the Fetus and Placenta also consume a proportion of maternal Thyroid Hormone and Iodine.']	N/A	N/A	[('UBERON_0000312', 'inner cambium layer of periosteum', 4, 'fetus'), ('UBERON_0001987', 'placenta', 14, 'placenta'), ('CHEBI_60311', 'thyroid hormone', 61, 'thyroid hormone'), ('UBERON_0002046', 'thyroid gland', 61, 'thyroid'), ('CHEBI_24859', 'iodine atom', 81, 'iodine')]
PMC3134395	6/2011	S40-PMC3134395	['the fetal Thyroid is capable of organifying Iodine by approximately the 20th week of Gestation.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 10, 'thyroid'), ('CHEBI_24859', 'iodine atom', 44, 'iodine'), ('GO_0007565', 'female pregnancy', 85, 'gestation')]
PMC3134395	6/2011	S43-PMC3134395	['once fetal Thyroid Gland function is established, fetal Thyroidal turnover of Iodine is much higher than Adult [7].']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 11, 'thyroid gland'), ('UBERON_0002046', 'thyroid gland', 56, 'thyroidal'), ('CHEBI_24859', 'iodine atom', 78, 'iodine'), ('UBERON_0007023', 'adult organism', 105, 'adult')]
PMC3134395	6/2011	S131-PMC3134395	['no difference was found in maternal or Cord Blood Thyroid Hormone levels.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 39, 'cord'), ('UBERON_0000178', 'blood', 44, 'blood'), ('CHEBI_60311', 'thyroid hormone', 50, 'thyroid hormone'), ('UBERON_0002046', 'thyroid gland', 50, 'thyroid')]
PMC3236407	11/2012	S89-PMC3236407	['physiologic stimulation of the Thyroid Gland is common in early Pregnancy due to the structural similarity between hcg and tsh, as previously stated [23].']	N/A	N/A	[('GO_0046654', 'tetrahydrofolate biosynthetic process', 31, 'thyroid gland'), ('UBERON_0002046', 'thyroid gland', 31, 'thyroid gland'), ('GO_0007565', 'female pregnancy', 64, 'pregnancy')]
PMC3272870	12/2011	S1-PMC3272870	['therefore, Pregnancy following Thyroid cancer is not infrequent, and about 10% of Thyroid cancers occurring during the Reproductive years are diagnosed during Pregnancy or in the early post-Partum period.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 11, 'pregnancy'), ('UBERON_0002046', 'thyroid gland', 31, 'thyroid'), ('UBERON_0002046', 'thyroid gland', 82, 'thyroid'), ('GO_0000003', 'reproduction', 119, 'reproductive'), ('GO_0007565', 'female pregnancy', 159, 'pregnancy'), ('GO_0007567', 'parturition', 190, 'partum')]
PMC3272870	12/2011	S7-PMC3272870	['introduction\nThyroid cancer, the most common Endocrine malignancy, is often detected in young patients and is more frequently diagnosed in women.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 13, 'Thyroid'), ('UBERON_0002049', 'vasculature', 45, 'endocrine')]
PMC3272870	12/2011	S11-PMC3272870	['therefore, Pregnancy in Thyroid cancer patients is not unusual, and about 10% of Thyroid cancers occurring during Reproductive years are diagnosed during Pregnancy or in the early post-Partum period.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 11, 'pregnancy'), ('UBERON_0002046', 'thyroid gland', 24, 'thyroid'), ('UBERON_0002046', 'thyroid gland', 81, 'thyroid'), ('GO_0000003', 'reproduction', 114, 'reproductive'), ('GO_0007565', 'female pregnancy', 154, 'pregnancy'), ('GO_0007567', 'parturition', 185, 'partum')]
PMC3272870	12/2011	S23-PMC3272870	['physiology of Pregnancy\n\nthyroid hormones and Foetal Development\nthe first Endocrine structure to appear during Embryonic Development is the Thyroid Gland.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 14, 'pregnancy'), ('GO_0060324', 'face development', 46, 'foetal development'), ('GO_0006397', 'mRNA processing', 75, 'endocrine'), ('UBERON_0002049', 'vasculature', 75, 'endocrine'), ('GO_0009790', 'embryo development', 112, 'embryonic development'), ('UBERON_0000922', 'embryo', 112, 'embryonic'), ('UBERON_0002046', 'thyroid gland', 141, 'thyroid gland')]
PMC3272870	12/2011	S24-PMC3272870	['at 10-12 weeks of Embryo Development, follicles containing colloid become visible, and the Thyroid is able to incorporate Iodine into Thyroid hormones.']	N/A	N/A	[('GO_0009790', 'embryo development', 18, 'embryo development'), ('UBERON_0000922', 'embryo', 18, 'embryo'), ('UBERON_0002046', 'thyroid gland', 91, 'thyroid'), ('CHEBI_24859', 'iodine atom', 122, 'iodine'), ('CHEBI_9437', 'temoporfin', 134, 'thyroid'), ('UBERON_0002046', 'thyroid gland', 134, 'thyroid')]
PMC3272870	12/2011	S28-PMC3272870	['the mother is the only source of foetal Thyroid hormones from Conception to approximately 13 weeks of Gestation, when foetal Thyroid function has developed14-16.']	N/A	N/A	[('CHEBI_9437', 'temoporfin', 40, 'thyroid'), ('UBERON_0002046', 'thyroid gland', 40, 'thyroid'), ('GO_0007620', 'copulation', 62, 'conception'), ('GO_0007565', 'female pregnancy', 102, 'gestation'), ('UBERON_0002046', 'thyroid gland', 125, 'thyroid')]
PMC3272870	12/2011	S59-PMC3272870	['there are some differences in the management of the two most important histotypes: dtc (differentiated Thyroid cancer: follicular and papillary cancer) and mtc (Medullary Thyroid cancer) just as for non-Pregnant patients [boxes 1-2].']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 103, 'thyroid'), ('UBERON_0004827', 'thyroid gland medulla', 161, 'medullary thyroid'), ('GO_0007565', 'female pregnancy', 203, 'pregnant')]
PMC3272870	12/2011	S70-PMC3272870	['according to the extent of the disease, hemithyroidectomy or radical Thyroidectomy is performed.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 69, 'thyroidectomy')]
PMC3272870	12/2011	S75-PMC3272870	['when radical Thyroidectomy is performed, the second most frequently used post-operative adjuvant therapy for non-Pregnant patients with dtc is Radioactive Iodine (rai, i-131) administered to eradicate persistent Neck disease or distant metastatic lesions.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 13, 'thyroidectomy'), ('GO_0007565', 'female pregnancy', 113, 'pregnant'), ('CHEBI_16706', '2-iodophenol', 143, 'radioactive iodine'), ('UBERON_0000974', 'neck', 212, 'neck')]
PMC3272870	12/2011	S85-PMC3272870	['the occurrence of mtc in both sporadic and familial forms makes the clinical approach to this tumour different from that to other Thyroid tumours.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 130, 'thyroid')]
PMC3365381	3/2011	S28-PMC3365381	['these are mainly Steroids and the hormones of Thyroid Gland, t3 and t4.']	N/A	N/A	[('CHEBI_35341', 'steroid', 17, 'steroids'), ('UBERON_0002046', 'thyroid gland', 46, 'thyroid gland')]
PMC3365381	3/2011	S132-PMC3365381	['the disturbance of methylation pattern can be shown as well as in the case of (not des provoked) Prostate, Colon, Thyroid, Gaster, Uterine, and Cervical carcinoma (li et al.2003b).']	N/A	N/A	[('UBERON_0002367', 'prostate gland', 97, 'prostate'), ('UBERON_0001155', 'colon', 107, 'colon'), ('UBERON_0002046', 'thyroid gland', 114, 'thyroid'), ('UBERON_0000942', 'frontal nerve (branch of ophthalmic)', 123, 'gaster'), ('UBERON_0000995', 'uterus', 131, 'uterine'), ('UBERON_0005434', 'cervical region', 144, 'cervical')]
PMC3404662	4/2012	S288-PMC3404662	['2006maternal hypothyroxinemiainsufficient Gestational Thyroid hormonesdecreased t4, inhibition of t4 deiodination to t3, prevention of Iodine Uptakeacetochlor, alachlor, Mancozeb, Thiocyanates, 2,4-D, aminotriazole, endosulfan, malathion (multiple Animal studies)Ocs, Thiocyanates, opscheek et al.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 42, 'gestational'), ('UBERON_0002046', 'thyroid gland', 54, 'thyroid'), ('CHEBI_24859', 'iodine atom', 135, 'iodine'), ('GO_0042757', 'giant axon', 142, 'uptakeAcetochlor'), ('CHEBI_52492', 'mancozeb', 170, 'mancozeb'), ('CHEBI_26965', 'thioglycines', 180, 'thiocyanates'), ('CHEBI_28854', '2,4-D', 194, '2,4-D'), ('NCBITaxon_33208', 'Metazoa', 248, 'animal'), ('CL_0000601', 'outer hair cell', 263, 'OCs'), ('CHEBI_26965', 'thioglycines', 268, 'thiocyanates')]
PMC3407995	7/2012	S121-PMC3407995	['the two Thyroid hormones that contain Iodine are thyroxine (t4) and Triiodothyronine (t3), the later being the biologically active form.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 8, 'thyroid'), ('CHEBI_24859', 'iodine atom', 38, 'iodine'), ('CHEBI_26982', 'threo-3-methylmalic acid', 68, 'triiodothyronine')]
PMC3407995	7/2012	S123-PMC3407995	['within the body, dietary Iodine mixes with circulating Iodine originating from Iodine Molecules removed from Thyroid hormones to create a pool of Inorganic Iodide available for Metabolic use [68].']	N/A	N/A	[('CHEBI_24859', 'iodine atom', 25, 'iodine'), ('CHEBI_24859', 'iodine atom', 55, 'iodine'), ('CHEBI_24859', 'iodine atom', 79, 'iodine'), ('CHEBI_36357', 'polyatomic entity', 86, 'molecules'), ('UBERON_0002046', 'thyroid gland', 109, 'thyroid'), ('CHEBI_35177', '2-oxohexanoate', 146, 'inorganic iodide'), ('GO_0008152', 'metabolic process', 177, 'metabolic')]
PMC3407995	7/2012	S125-PMC3407995	['in a healthy non-Pregnant woman with adequate Iodine Intake, the absorbed dietary Iodine balances Renal Iodide clearance and the Thyroid maintains a normal Iodine store of 15–20 mg [69].']	N/A	N/A	[('GO_0007565', 'female pregnancy', 17, 'pregnant'), ('CHEBI_24859', 'iodine atom', 46, 'iodine'), ('GO_0007631', 'feeding behavior', 53, 'intake'), ('CHEBI_24859', 'iodine atom', 82, 'iodine'), ('UBERON_0002113', 'kidney', 98, 'renal'), ('CHEBI_16382', 'iodide', 104, 'iodide'), ('UBERON_0002046', 'thyroid gland', 129, 'thyroid'), ('CHEBI_24859', 'iodine atom', 156, 'iodine')]
PMC3407995	7/2012	S128-PMC3407995	['the rate of maternal Thyroid Hormone Production returns to normal following Birth.']	N/A	N/A	[('CHEBI_9437', 'temoporfin', 21, 'thyroid'), ('GO_0032640', 'tumor necrosis factor production', 21, 'thyroid hormone production'), ('UBERON_0002046', 'thyroid gland', 21, 'thyroid'), ('GO_0007567', 'parturition', 76, 'birth')]
PMC3407995	7/2012	S130-PMC3407995	['Iodine is stored in the Thyroid Gland and any excess consumed Iodine is Excreted in the Urine [66].']	N/A	N/A	[('CHEBI_31719', 'ipriflavone', 0, 'Iodine'), ('UBERON_0002046', 'thyroid gland', 24, 'thyroid gland'), ('CHEBI_24859', 'iodine atom', 62, 'iodine'), ('GO_0007588', 'excretion', 72, 'excreted'), ('UBERON_0001088', 'urine', 88, 'urine')]
PMC3407995	7/2012	S349-PMC3407995	['a national, kyrgyzstan population-representative survey during autumn 2007 collected household Salt and Urine samples of school-age children and Pregnant women for quantitative Iodine measurements and measured maternal Thyroid volume.']	N/A	N/A	[('CHEBI_24866', 'salt', 95, 'salt'), ('UBERON_0001088', 'urine', 104, 'urine'), ('GO_0007565', 'female pregnancy', 145, 'pregnant'), ('CHEBI_24859', 'iodine atom', 177, 'iodine'), ('UBERON_0002046', 'thyroid gland', 219, 'thyroid')]
PMC3407995	7/2012	S361-PMC3407995	['a significant percentage of women had a sub-normal Serum Thyroid hormone concentration at full term.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 51, 'serum'), ('UBERON_0002046', 'thyroid gland', 57, 'thyroid')]
PMC3407995	7/2012	S365-PMC3407995	['a cross-sectional study conducted in iran between 1996 and 1998 in 403 Pregnant women and a study of 100 Lactating women conducted in 2003 included evaluated Thyroid size, and both Urinary and Breast Milk Iodine concentrations.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 71, 'pregnant'), ('GO_0007594', 'puparial adhesion', 105, 'lactating'), ('UBERON_0002046', 'thyroid gland', 158, 'thyroid'), ('UBERON_0001088', 'urine', 181, 'urinary'), ('UBERON_0000310', 'breast', 193, 'breast'), ('UBERON_0001913', 'milk', 200, 'milk'), ('CHEBI_24859', 'iodine atom', 205, 'iodine')]
PMC3407995	7/2012	S369-PMC3407995	['a study including 433 Pregnant and 95 non-Pregnant women in tayside, scotland, mean Gestational age at recruitment of 11.5 weeks measured Urinary Iodine and a range of Thyroid hormones.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 22, 'pregnant'), ('GO_0007565', 'female pregnancy', 42, 'pregnant'), ('GO_0007565', 'female pregnancy', 84, 'gestational'), ('UBERON_0001088', 'urine', 138, 'urinary'), ('CHEBI_24859', 'iodine atom', 146, 'iodine'), ('UBERON_0002046', 'thyroid gland', 168, 'thyroid')]
PMC3407995	7/2012	S379-PMC3407995	['of the 62 women with Thyroid deficiency, 48 were not treated for the condition during the Pregnancy under study.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 21, 'thyroid'), ('GO_0007565', 'female pregnancy', 90, 'pregnancy')]
PMC3470091	9/2012	S28-PMC3470091	['the patients had gdm if 50 g resulted in a Glucose Serum concentration of 7.2 mmol/lit, and if 100 g gtt test was disturbed on the basis of carpenter and coustan criteria.25the study inclusion criteria were the absence of Thyroid, Kidney and Liver diseases as well as malabsorption.']	N/A	N/A	[('CHEBI_17234', 'glucose', 43, 'glucose'), ('UBERON_0001977', 'blood serum', 51, 'serum'), ('UBERON_0002046', 'thyroid gland', 222, 'thyroid'), ('UBERON_0002113', 'kidney', 231, 'kidney'), ('UBERON_0002107', 'liver', 242, 'liver')]
PMC3503401	11/2012	S4-PMC3503401	['Blood samples were taken from 367 women at their first Antenatal visit between 7 and 11 weeks Gestation for measurement of Thyroid Stimulating Hormone (Tsh) and free thyroxine (ft4) levels and spot Urine samples for Urinary Iodine Excretion were taken at the same time as Blood collection.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('GO_0007567', 'parturition', 55, 'antenatal'), ('GO_0007565', 'female pregnancy', 94, 'gestation'), ('UBERON_0002046', 'thyroid gland', 123, 'thyroid'), ('CHEBI_66524', 'streptokordin', 131, 'stimulating hormone'), ('CHEBI_17855', 'triglyceride', 152, 'TSH'), ('UBERON_0001088', 'urine', 198, 'urine'), ('UBERON_0001088', 'urine', 216, 'urinary'), ('CHEBI_24859', 'iodine atom', 224, 'iodine'), ('GO_0007588', 'excretion', 231, 'excretion'), ('UBERON_0000178', 'blood', 272, 'blood')]
PMC3503401	11/2012	S10-PMC3503401	['there was no statistically significant association between uic and Thyroid function and no evidence for an effect of Iodine Intake on Thyroid function.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 67, 'thyroid'), ('CHEBI_24859', 'iodine atom', 117, 'iodine'), ('GO_0007631', 'feeding behavior', 124, 'intake'), ('UBERON_0002046', 'thyroid gland', 134, 'thyroid')]
PMC3503401	11/2012	S18-PMC3503401	['inadequate Iodine supply to the Thyroid Gland will result in decreased Thyroid Hormone Synthesis and enlargement of the Gland.']	N/A	N/A	[('CHEBI_24859', 'iodine atom', 11, 'iodine'), ('UBERON_0002046', 'thyroid gland', 32, 'thyroid gland'), ('CHEBI_9437', 'temoporfin', 71, 'thyroid'), ('GO_0007565', 'female pregnancy', 71, 'thyroid'), ('UBERON_0002046', 'thyroid gland', 71, 'thyroid'), ('GO_0042446', 'hormone biosynthetic process', 79, 'hormone synthesis'), ('UBERON_0002530', 'gland', 120, 'gland')]
PMC3503401	11/2012	S31-PMC3503401	['at the same time Thyroid function tests, Thyroid Antibodies, and Urinary Iodine concentrations were measured.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 17, 'thyroid'), ('UBERON_0002046', 'thyroid gland', 41, 'thyroid'), ('GO_0042571', 'immunoglobulin complex, circulating', 49, 'antibodies'), ('UBERON_0001088', 'urine', 65, 'urinary'), ('CHEBI_24859', 'iodine atom', 73, 'iodine')]
PMC3503401	11/2012	S32-PMC3503401	['the patients answered questions in relation to their dietary habits, Vitamin and Mineral supplementation, and family history of Thyroid disease.']	N/A	N/A	[('CHEBI_33229', 'vitamin (role)', 69, 'vitamin'), ('CHEBI_46662', 'mineral', 81, 'mineral'), ('UBERON_0002046', 'thyroid gland', 128, 'thyroid')]
PMC3503401	11/2012	S49-PMC3503401	['a personal history or family history of Thyroid dysfunction was obtained, and dietary questions were asked in relation to servings of Milk and dairy products per day and portions of fish per week over the preceding weeks of the Pregnancy.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 40, 'thyroid'), ('UBERON_0001913', 'milk', 134, 'milk'), ('GO_0007565', 'female pregnancy', 228, 'pregnancy')]
PMC3503401	11/2012	S66-PMC3503401	['there was no statistically significant association between uic and parity, ethnicity, and history of Thyroid disease.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 101, 'thyroid')]
PMC3503401	11/2012	S104-PMC3503401	['from western australia [14], examining Thyroid function during the first Trimester of Pregnancy in a large sample (excluding women with positive Thyroid Autoantibodies), they reported a reference range for Serum Tsh of 0.4 to 4.0\u2009miu/l and for Serum free t4 of 9.0 to 19\u2009pmol/l.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 39, 'thyroid'), ('GO_0009294', 'DNA mediated transformation', 73, 'trimester'), ('GO_0007565', 'female pregnancy', 86, 'pregnancy'), ('UBERON_0002046', 'thyroid gland', 145, 'thyroid'), ('GO_0044308', 'axonal spine', 153, 'autoantibodies'), ('UBERON_0001977', 'blood serum', 206, 'serum'), ('CHEBI_17855', 'triglyceride', 212, 'TSH'), ('UBERON_0001977', 'blood serum', 244, 'serum')]
PMC3509517	11/2012	S46-PMC3509517	['in 1922, david cowie, chairman of the pediatrics department at the university of michigan, proposed at a michigan state medical society Thyroid symposium that the u.s. adopt Salt iodization to eliminate simple goiter [12].']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 136, 'thyroid'), ('CHEBI_24866', 'salt', 174, 'salt')]
PMC3556415	1/2013	S1-PMC3556415	['an enlargement of the anterior left Neck Region was noted on the palpation of the Thyroid Gland.']	N/A	N/A	[('UBERON_0005434', 'cervical region', 36, 'neck region'), ('UBERON_0002046', 'thyroid gland', 82, 'thyroid gland')]
PMC3556415	1/2013	S21-PMC3556415	['an enlargement of the left Neck Region was noted on palpation of the Thyroid Gland, with no enlarged Peripheral Lymph Nodes.']	N/A	N/A	[('UBERON_0005434', 'cervical region', 27, 'neck region'), ('UBERON_0002046', 'thyroid gland', 69, 'thyroid gland'), ('UBERON_0003922', 'pancreatic epithelial bud', 101, 'peripheral lymph nodes')]
PMC3556415	1/2013	S23-PMC3556415	['all laboratory investigations, including full Blood count, Liver function tests, and Thyroid function tests were within normal range.']	N/A	N/A	[('UBERON_0000178', 'blood', 46, 'blood'), ('UBERON_0002107', 'liver', 59, 'liver'), ('UBERON_0002046', 'thyroid gland', 85, 'thyroid')]
PMC3556415	1/2013	S29-PMC3556415	['imaging studies included an ultrasound of the Thyroid Gland showing a normal-sized Gland with the presence of a mass displacing the Left Thyroid Lobe and the Vessels of the left Neck Region.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 46, 'thyroid gland'), ('UBERON_0002530', 'gland', 83, 'gland'), ('UBERON_0001120', 'left lobe of thyroid gland', 132, 'left thyroid lobe'), ('UBERON_0000055', 'vessel', 158, 'vessels'), ('UBERON_0005434', 'cervical region', 178, 'neck region')]
PMC3556415	1/2013	S30-PMC3556415	['an mri of the Neck revealed a normal sized Thyroid, Larynx and Lymph Nodes, and a marked Esophageal dilatation with the presence of Food remnants along its length with displacement of the Trachea to the right (figures1and2).']	N/A	N/A	[('UBERON_0000974', 'neck', 14, 'neck'), ('UBERON_0002046', 'thyroid gland', 43, 'thyroid'), ('UBERON_0001737', 'larynx', 52, 'larynx'), ('UBERON_0000029', 'lymph node', 63, 'lymph nodes'), ('UBERON_0011358', 'infundibular organ', 89, 'esophageal'), ('CHEBI_33290', 'food', 132, 'food'), ('UBERON_0003126', 'trachea', 188, 'trachea')]
PMC3571634	12/2012	S39-PMC3571634	['quantification of fasting and Postprandial Blood Glucose levels\nFinger prick Blood samples were collected before the start of the meal, and at 15, 30, 45, 60, 75, 90 and 120 min after the start of the meal.']	N/A	N/A	[('GO_0008283', 'cell proliferation', 30, 'Postprandial'), ('UBERON_0000178', 'blood', 43, 'Blood'), ('CHEBI_17234', 'glucose', 49, 'Glucose'), ('UBERON_0002046', 'thyroid gland', 64, 'Finger'), ('UBERON_0000178', 'blood', 77, 'blood')]
PMC3603018	12/2012	S13-PMC3603018	['in women with normal Thyroid function, there is an increase in thyroxine (t4) and Triiodothyronine (t3) Production, which results in inhibition of Thyroid-Stimulating Hormone (Tsh) in the first Trimester of Pregnancy, due to a high Human Chorionic Gonadotropin (hcg) level that stimulates the tsh receptor because of partial structural similarity[12] [figure 1].']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 21, 'thyroid'), ('CHEBI_26982', 'threo-3-methylmalic acid', 82, 'triiodothyronine'), ('GO_0001555', 'oocyte growth', 104, '... production'), ('UBERON_0002046', 'thyroid gland', 147, 'thyroid'), ('CHEBI_66524', 'streptokordin', 155, 'stimulating hormone'), ('PR_000015909', 'synaptotagmin-7', 155, 'stimulating hormone'), ('CHEBI_17855', 'triglyceride', 176, 'TSH'), ('PR_000016711', 'TSC22 domain family protein 1', 176, 'TSH'), ('GO_0009294', 'DNA mediated transformation', 194, 'trimester'), ('GO_0007565', 'female pregnancy', 207, 'pregnancy'), ('NCBITaxon_9606', 'Homo sapiens', 232, 'human'), ('UBERON_0003124', 'chorion', 238, 'chorionic'), ('PR_000001220', 'encephalopsin', 248, 'gonadotropin')]
PMC3603018	12/2012	S18-PMC3603018	['[4]\nthe typical case is a women in the first Trimester of Pregnancy who is referred with a high tsh value with the free Thyroid Hormones in the low normal range or with frank hypothyroidism and in certain instances with biochemical euthyroxinemia with Tpo Antibody positivity.']	N/A	N/A	[('GO_0009294', 'DNA mediated transformation', 45, 'trimester'), ('GO_0007565', 'female pregnancy', 58, 'pregnancy'), ('CHEBI_26935', 'tetraterpenoid', 120, 'thyroid hormones'), ('UBERON_0002046', 'thyroid gland', 120, 'thyroid'), ('PR_000016585', 'tripeptidyl-peptidase 1', 252, 'TPO'), ('GO_0042571', 'immunoglobulin complex, circulating', 256, 'antibody')]
PMC3603018	12/2012	S33-PMC3603018	['in women who had started their Thyroxine in Pregnancy for subclinical hypothyroidism, the Medication can be stopped after Delivery and Thyroid balance re-assessed again after six weeks and decision taken regarding continuation of treatment.']	N/A	N/A	[('CHEBI_17842', 'trypanothione', 31, 'thyroxine'), ('GO_0007565', 'female pregnancy', 44, 'pregnancy'), ('CHEBI_60211', 'compound Z', 90, 'medication'), ('GO_0007567', 'parturition', 122, 'delivery'), ('UBERON_0002046', 'thyroid gland', 135, 'thyroid')]
PMC3603018	12/2012	S46-PMC3603018	['for People diagnosed in the current Pregnancy, we straightway start with Anti-Thyroid Medication.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 4, 'people'), ('GO_0007565', 'female pregnancy', 36, 'pregnancy'), ('CHEBI_50339', '4-aminobutyl group', 73, 'anti-thyroid medication'), ('UBERON_0002046', 'thyroid gland', 78, 'thyroid')]
PMC3607807	3/2013	S237-PMC3607807	['Iodine deficiency manifests in hypothyroidism, causing underproduction of Thyroid hormones including triiodothyronin (t3) and thyroxin (t4).']	N/A	N/A	[('CHEBI_31719', 'ipriflavone', 0, 'Iodine'), ('UBERON_0002046', 'thyroid gland', 74, 'thyroid')]
PMC3613945	2/2013	S268-PMC3613945	['Thyroid Autoimmune disease\ngraves’ disease and hashimoto thyroidosis are the two common forms of Autoimmune Thyroid disease.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 0, 'Thyroid'), ('UBERON_0001442', 'skeleton of manus', 8, 'autoimmune'), ('UBERON_0001442', 'skeleton of manus', 97, 'autoimmune'), ('UBERON_0002046', 'thyroid gland', 108, 'thyroid')]
PMC3615950	3/2013	S151-PMC3615950	['in the first case it is suitable to send the patient to a specialist center because of the high probability of secondary hypertension, whereas in the second case the presence of Peripheral Pulses and negative results of simple diagnostic tests (Blood sodium, potassium, creatinine, Thyroid hormones, Urine test) would direct towards the diagnosis of essential hypertension.']	N/A	N/A	[('UBERON_0000121', 'perineurium', 178, 'peripheral pulses'), ('UBERON_0000178', 'blood', 245, 'blood'), ('UBERON_0002046', 'thyroid gland', 282, 'thyroid'), ('UBERON_0001088', 'urine', 300, 'urine')]
PMC3622346	3/2013	S73-PMC3622346	['examples of noncardiogenic Pulmonary edema are iatrogenic Fluid overload, Thyroid disease, Drug-induced Pulmonary edema (e.g., Tocolytic therapy and Oxytocin), acute Respiratory distress syndrome (ards), and preeclampsia-related Pulmonary edema.']	N/A	N/A	[('UBERON_0002048', 'lung', 27, 'pulmonary'), ('UBERON_0006314', 'bodily fluid', 58, 'fluid'), ('UBERON_0002046', 'thyroid gland', 74, 'thyroid'), ('CHEBI_23888', 'drug', 91, 'drug'), ('UBERON_0002048', 'lung', 104, 'pulmonary'), ('GO_0034390', 'smooth muscle cell apoptotic process', 127, 'tocolytic'), ('CHEBI_7872', 'oxytocin', 149, 'oxytocin'), ('UBERON_0001004', 'respiratory system', 166, 'respiratory'), ('UBERON_0002048', 'lung', 229, 'pulmonary')]
PMC3622346	3/2013	S86-PMC3622346	['other workup showed normal tsh level which also ruled out Thyroid-related conditions.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 58, 'thyroid')]
PMC3640235	10/2012	S117-PMC3640235	['Autoimmune Thyroid disease is present in 5-20% of unselected Pregnant women.']	N/A	N/A	[('UBERON_0005445', 'segment of pes', 0, 'Autoimmune'), ('UBERON_0002046', 'thyroid gland', 11, 'thyroid'), ('GO_0007565', 'female pregnancy', 61, 'pregnant')]
PMC3652177	4/2013	S91-PMC3652177	['if the Prechordal Plate Cells are inhibited in their migration as they are by Lithium exposure, then cells in the wnt-Expressing Valve regions are much more sparse than seen in control Embryos and abnormal Valvular function was observed in the experimental Embryos [4].']	N/A	N/A	[('UBERON_0003063', 'prechordal plate', 7, 'prechordal plate'), ('CL_0000233', 'platelet', 18, 'plate cells'), ('CHEBI_52634', 'sodium-23 atom', 78, 'lithium'), ('GO_0010467', 'gene expression', 118, 'expressing'), ('UBERON_0003978', 'valve', 129, 'valve'), ('UBERON_0000922', 'embryo', 185, 'embryos'), ('UBERON_0002046', 'thyroid gland', 206, 'valvular'), ('UBERON_0000922', 'embryo', 257, 'embryos')]
PMC3657451	4/2013	S1-PMC3657451	['to investigate obstetric features of Pregnant women with Thyroid disorders and Thyroid function tests of their newborn infants.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 37, 'pregnant'), ('UBERON_0002046', 'thyroid gland', 57, 'thyroid'), ('UBERON_0002046', 'thyroid gland', 79, 'thyroid')]
PMC3657451	4/2013	S3-PMC3657451	['women with hypothyroidism and having anti-thyroglobulin (atg) and anti-Thyroid peroxidase (anti-Tpo) Antibodies were assigned as group i, women with hypothyroidism who did not have Autoantibodies were assigned as group ii, and women without Thyroid problems were assigned as group iii.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 71, 'thyroid'), ('PR_000016585', 'tripeptidyl-peptidase 1', 96, 'TPO'), ('GO_0042571', 'immunoglobulin complex, circulating', 101, 'antibodies'), ('GO_0044308', 'axonal spine', 181, 'autoantibodies'), ('UBERON_0002046', 'thyroid gland', 241, 'thyroid')]
PMC3657451	4/2013	S7-PMC3657451	['five infants (23.8%) in group ii had Thyroid-Stimulating Hormone (Tsh) levels >20\u2009miu/ml.']	N/A	N/A	[('CHEBI_9437', 'temoporfin', 37, 'thyroid'), ('UBERON_0002046', 'thyroid gland', 37, 'thyroid'), ('CHEBI_66524', 'streptokordin', 45, 'stimulating hormone'), ('CHEBI_17855', 'triglyceride', 66, 'TSH')]
PMC3657451	4/2013	S28-PMC3657451	['primary congenital hypothyroidism consists of disorders of Thyroid Development or of Thyroid Hormone Synthesis [15–17].']	N/A	N/A	[('GO_0008584', 'male gonad development', 59, 'thyroid development'), ('UBERON_0002046', 'thyroid gland', 59, 'thyroid'), ('CHEBI_60311', 'thyroid hormone', 85, 'thyroid hormone'), ('GO_0042412', 'taurine biosynthetic process', 85, 'thyroid hormone synthesis'), ('UBERON_0002046', 'thyroid gland', 85, 'thyroid')]
PMC3657451	4/2013	S34-PMC3657451	['methods\nthe study group consisted of the Pregnant women with Thyroid disorders followed in the obstetric outpatient clinic at marmara unıversity hospital in turkey, in 2008–2010.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 41, 'pregnant'), ('UBERON_0002046', 'thyroid gland', 61, 'thyroid')]
PMC3657451	4/2013	S36-PMC3657451	['three control mothers were enrolled for each mother with Thyroid disorder.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 57, 'thyroid')]
PMC3657451	4/2013	S37-PMC3657451	['the definition of maternal hypothyroidism was based on the diagnosis of an endocrinologist, and Thyroid hormone replacement was done throughout Pregnancy.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 96, 'thyroid'), ('GO_0007565', 'female pregnancy', 144, 'pregnancy')]
PMC3657451	4/2013	S38-PMC3657451	['during clinical followup, Thyroid function tests including Ft4 and tsh and Thyroid autoantibody titers (anti-Tpo and Atg) were measured.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 26, 'thyroid'), ('PR_000007702', 'galactoside alpha-(1,2)-fucosyltransferase 1', 59, 'FT4'), ('UBERON_0002046', 'thyroid gland', 75, 'thyroid'), ('PR_000016585', 'tripeptidyl-peptidase 1', 109, 'TPO'), ('PR_000004405', 'activating transcription factor 7-interacting protein 1', 117, 'ATG')]
PMC3657451	4/2013	S40-PMC3657451	['hypothyroid women with positive atg and anti-Tpo titers were assigned as group i ( n = 13), and those who did not have Autoantibodies were assigned as group ii ( n = 21), while women without Thyroid problems were assigned as group iii ( n = 92).']	N/A	N/A	[('PR_000016585', 'tripeptidyl-peptidase 1', 45, 'TPO'), ('GO_0044308', 'axonal spine', 119, 'autoantibodies'), ('UBERON_0002046', 'thyroid gland', 191, 'thyroid')]
PMC3657451	4/2013	S42-PMC3657451	['Thyroid tests of the infants were measured in the first Postnatal week and third Postnatal week in the study group.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 0, 'Thyroid'), ('GO_0007567', 'parturition', 56, 'postnatal'), ('GO_0007567', 'parturition', 81, 'postnatal')]
PMC3657451	4/2013	S67-PMC3657451	['in the followup, Thyroid functions tests were entirely normal at the 8th Postnatal week.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 17, 'thyroid'), ('GO_0007567', 'parturition', 73, 'postnatal')]
PMC3657451	4/2013	S78-PMC3657451	['the infants of hypothyroid mothers had higher recall rate in newborn Tsh screening and transient Thyroid dysfunction in the first 8 weeks of Life.']	N/A	N/A	[('CHEBI_17855', 'triglyceride', 69, 'TSH'), ('UBERON_0002046', 'thyroid gland', 97, 'thyroid'), ('UBERON_0000104', 'life cycle', 141, 'life')]
PMC3657451	4/2013	S80-PMC3657451	['the frequency of Thyroid deficiency varies among Pregnant women in different countries and ranges between 0.19% in japan and as high as 2.2% in belgium and 2.5% in the united states [18–20].']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 17, 'thyroid'), ('GO_0007565', 'female pregnancy', 49, 'pregnant')]
PMC3657451	4/2013	S83-PMC3657451	['Pregnancy causes increased Thyroid Gland vascularity, increased Renal Iodide clearance, and Iodide losses to the foetus [1].']	N/A	N/A	[('GO_0007565', 'female pregnancy', 0, 'Pregnancy'), ('UBERON_0002046', 'thyroid gland', 27, 'thyroid gland'), ('UBERON_0002113', 'kidney', 64, 'renal'), ('CHEBI_16382', 'iodide', 70, 'iodide'), ('CHEBI_16382', 'iodide', 92, 'iodide')]
PMC3657451	4/2013	S91-PMC3657451	['Autoimmune Thyroid disease is common in Pregnancy.']	N/A	N/A	[('UBERON_0005445', 'segment of pes', 0, 'Autoimmune'), ('UBERON_0002046', 'thyroid gland', 11, 'thyroid'), ('GO_0007565', 'female pregnancy', 40, 'pregnancy')]
PMC3660281	5/2013	S68-PMC3660281	['multiple endocrine neoplasia type 2b (men 2b) is an Autosomal dominant complex oncologic neurocristopathy including Medullary Thyroid carcinoma, pheochromocytoma, Gastrointestinal disorders, marphanoid Face, and Mucosal multiple ganglioneuromas.']	N/A	N/A	[('GO_0030849', 'autosome', 52, 'autosomal'), ('UBERON_0000958', 'medulla of organ', 116, 'medullary'), ('UBERON_0002046', 'thyroid gland', 126, 'thyroid'), ('UBERON_0005409', 'alimentary part of gastrointestinal system', 163, 'gastrointestinal'), ('UBERON_0001456', 'face', 202, 'face'), ('UBERON_0000344', 'mucosa', 212, 'mucosal')]
PMC3660281	5/2013	S73-PMC3660281	["other ret mutations cause men 2a syndrome, familial Medullary Thyroid carcinoma, or hirschsprung's disease."]	N/A	N/A	[('UBERON_0000958', 'medulla of organ', 52, 'medullary'), ('UBERON_0002046', 'thyroid gland', 62, 'thyroid')]
PMC3660281	5/2013	S80-PMC3660281	['the surgical treatment of men 2b is total Thyroidectomy with Cervical limphadenectomy of the central Compartment Of the Neck.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 42, 'thyroidectomy'), ('UBERON_0005434', 'cervical region', 61, 'cervical'), ('UBERON_0012420', 'coprodeum', 101, 'compartment of ... neck')]
PMC3683207	3/2013	S15-PMC3683207	['the uie in a non-Pregnant Individual on a stable diet represents a dynamic equilibrium between dietary Intake, Thyroidal Iodine extraction, the total body Thyroid Hormone pool, and gfr.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 17, 'pregnant'), ('NCBITaxon_1', 'root', 26, 'individual'), ('GO_0007631', 'feeding behavior', 103, 'intake'), ('UBERON_0002046', 'thyroid gland', 111, 'thyroidal'), ('CHEBI_24859', 'iodine atom', 121, 'iodine'), ('CHEBI_60311', 'thyroid hormone', 155, 'thyroid hormone'), ('UBERON_0002046', 'thyroid gland', 155, 'thyroid')]
PMC3683207	3/2013	S45-PMC3683207	['increased maternal Thyroid Hormone Synthesis to maintain euthyroidism and provide Thyroid Hormones to the fetus as well as transfer of Iodine to the fetus add to the increasing Iodine requirements during Pregnancy.']	N/A	N/A	[('CHEBI_60311', 'thyroid hormone', 19, 'thyroid hormone'), ('GO_0042412', 'taurine biosynthetic process', 19, 'thyroid hormone synthesis'), ('UBERON_0002046', 'thyroid gland', 19, 'thyroid'), ('CHEBI_26935', 'tetraterpenoid', 82, 'thyroid hormones'), ('UBERON_0002046', 'thyroid gland', 82, 'thyroid'), ('CHEBI_24859', 'iodine atom', 135, 'iodine'), ('CHEBI_24859', 'iodine atom', 177, 'iodine'), ('GO_0007565', 'female pregnancy', 204, 'pregnancy')]
PMC3809191	1/2013	S16-PMC3809191	['Serum fasting Insulin, 25 (Oh) D, creatinine, calcium (Ca), Phosphorus (p), magnesium (Mg), alkaline phosphatase (alp), Parathyroid hormone (pth), Thyroid-stimulating hormone (stsh), albumin, hba1c, Liver transaminases (ast and alt) were also measured and the body mass indexes (bmi) were calculated in all groups.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('PR_000045358', 'insulin family protein', 14, 'insulin'), ('CHEBI_71657', 'versiconol acetate', 23, '25 (OH) D'), ('CHEBI_32588', 'potassium chloride', 55, 'Ca'), ('CHEBI_35885', 'secondary phosphine', 60, 'phosphorus'), ('CHEBI_34829', 'Medrysone', 87, 'Mg'), ('UBERON_0001132', 'parathyroid gland', 120, 'parathyroid'), ('CHEBI_9437', 'temoporfin', 147, 'thyroid'), ('UBERON_0002046', 'thyroid gland', 147, 'thyroid'), ('UBERON_0002107', 'liver', 199, 'liver')]
PMC3877972	12/2013	S82-PMC3877972	['among the 101,163 Pregnant women, the incidence of lbw in infants Delivered in Teriary care hospitals was 7.1% (5523/77338), and the incidence of lbw in infants Delivered in secondary care hospitals was 2.6% (612/23825).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 18, 'pregnant'), ('GO_0007567', 'parturition', 66, 'delivered'), ('UBERON_0002046', 'thyroid gland', 79, 'teriary'), ('GO_0007567', 'parturition', 161, 'delivered')]
PMC3877972	12/2013	S83-PMC3877972	['the incidence of lbw in Teriary care hospitals was significantly higher than in secondary care hospitals (p\u2009<\u20090.001).']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 24, 'teriary')]
PMC4014765	3/2014	S40-PMC4014765	['eligibility criteria at enrollment included a ) 16 ± 3 weeks of Pregnancy, b ) age ≥ 18 years, c ) residence in a home built before 1978, d ) no history of hiv infection, and e ) no Medications taken for seizure or Thyroid disorders.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 64, 'pregnancy'), ('CHEBI_25441', 'mycothiols', 182, 'medications'), ('UBERON_0002046', 'thyroid gland', 215, 'thyroid')]
PMC4018592	4/2014	S32-PMC4018592	['multiparous women as well as those with hypertension, mild and severe pre-eclampsia, Intrauterine growth retardation (iugr), intra-Uterine fetal death, Gestational diabetes mellitus (gdm), completed bed rest (cbr), history or evidence of rheumatoid arthritis, Thyroid, Parathyroid or Adrenal diseases, Hepatic or Renal failure and metabolic bone disease were not included in the current study.']	N/A	N/A	[('UBERON_0022293', 'reproductive gland secretion', 85, 'intrauterine'), ('UBERON_0000995', 'uterus', 131, 'uterine'), ('GO_0007565', 'female pregnancy', 152, 'gestational'), ('UBERON_0002046', 'thyroid gland', 260, 'thyroid'), ('UBERON_0001132', 'parathyroid gland', 269, 'parathyroid'), ('UBERON_0002369', 'adrenal gland', 284, 'adrenal'), ('UBERON_0002107', 'liver', 302, 'hepatic'), ('UBERON_0002113', 'kidney', 313, 'renal')]
PMC4054662	7/2014	S49-PMC4054662	['the exclusion criteria were as follows: under 18 years old; current smokers (who have a lower risk of pre-eclampsia); taking any supplement containing se; taking Thyroid Medication; multiple Pregnancy; abnormal fetal anomaly scan; chronic proteinuria; Heparin treatment; hiv, Hep-B or hep-c positive; yeast intolerance (supplement contains yeast); inability or refusal to give informed consent (the Genetic component of the trial was omitted in those who did not give explicit consent to this aspect of the trial).']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 162, 'thyroid'), ('CHEBI_60211', 'compound Z', 170, 'medication'), ('GO_0007565', 'female pregnancy', 191, 'pregnancy'), ('CHEBI_28304', 'heparin', 252, 'heparin'), ('PR_000008840', 'huntingtin', 276, 'Hep-B'), ('SO_0000704', 'gene', 399, 'genetic')]
PMC4054662	7/2014	S57-PMC4054662	['chronic hypertension, diabetes, Thyroid disease; current medication; presence of severe morning sickness; alcohol use; vegetarian or not.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 32, 'thyroid')]
PMC4089555	5/2014	S9-PMC4089555	['introduction\nIodine, as its Water-soluble Iodide Ion (I−), is the rate-limiting substrate for Thyroid Hormone Synthesis.']	N/A	N/A	[('CHEBI_31719', 'ipriflavone', 13, 'Iodine'), ('CHEBI_15377', 'water', 28, 'water'), ('CHEBI_24853', 'intercalator', 42, 'iodide ion'), ('CHEBI_46750', 'hygrine', 54, 'I−),'), ('CHEBI_60311', 'thyroid hormone', 94, 'thyroid hormone'), ('GO_0042412', 'taurine biosynthetic process', 94, 'thyroid hormone synthesis'), ('UBERON_0002046', 'thyroid gland', 94, 'thyroid')]
PMC4089555	5/2014	S11-PMC4089555	['Iodide is absorbed in the Stomach and Duodenum and cleared by the Kidney and the Thyroid.']	N/A	N/A	[('CHEBI_5859', 'Icacine', 0, 'Iodide'), ('UBERON_0000945', 'stomach', 26, 'stomach'), ('UBERON_0002114', 'duodenum', 38, 'duodenum'), ('UBERON_0002113', 'kidney', 66, 'kidney'), ('UBERON_0002046', 'thyroid gland', 81, 'thyroid')]
PMC4089555	5/2014	S12-PMC4089555	['seventy to eighty percent of the Iodine body content is located in the Thyroid Gland and Thyroid Hormone Synthesis requires a series of Regulated steps.']	N/A	N/A	[('CHEBI_24859', 'iodine atom', 33, 'iodine'), ('UBERON_0002046', 'thyroid gland', 71, 'thyroid gland'), ('CHEBI_9437', 'temoporfin', 89, 'thyroid'), ('GO_0042412', 'taurine biosynthetic process', 89, 'thyroid hormone synthesis'), ('UBERON_0002046', 'thyroid gland', 89, 'thyroid'), ('GO_0065007', 'biological regulation', 136, 'regulated')]
PMC4089555	5/2014	S22-PMC4089555	['Iodide is rapidly cleared from the circulation by the Thyroid Gland and Kidneys.']	N/A	N/A	[('CHEBI_5859', 'Icacine', 0, 'Iodide'), ('UBERON_0002046', 'thyroid gland', 54, 'thyroid gland'), ('UBERON_0002113', 'kidney', 72, 'kidneys')]
PMC4089555	5/2014	S36-PMC4089555	['the secretion of Thyroid hormones at the Basolateral Membrane is shown in the blue boxes.']	N/A	N/A	[('CHEBI_9437', 'temoporfin', 17, 'thyroid'), ('UBERON_0002046', 'thyroid gland', 17, 'thyroid'), ('GO_0016323', 'basolateral plasma membrane', 41, 'basolateral membrane')]
PMC4089555	5/2014	S37-PMC4089555	['Iodide Transport In Thyroid Cells\nas illustrated in figure\xa01, the nis ( Slc5A5 ) , a member of the solute Carrier Family 5, located at the Basolateral Plasma Membrane Of the Thyroid Follicular Cells actively transports Iodide into the Thyroid using the electrochemical gradient generated by the Na,k-atpase [9-11].']	N/A	N/A	[('CHEBI_5859', 'Icacine', 0, 'Iodide'), ('GO_0043652', 'engulfment of apoptotic cell', 0, 'Iodide transport in ... cells'), ('CL_0000893', 'thymocyte', 20, 'thyroid cells'), ('UBERON_0002046', 'thyroid gland', 20, 'thyroid'), ('PR_000015190', 'sodium- and chloride-dependent glycine transporter 2', 72, 'SLC5A5'), ('PR_000004890', 'complement C1q tumor necrosis factor-related protein 8', 106, 'carrier family 5'), ('GO_1990794', 'basolateral part of cell', 139, 'basolateral'), ('GO_0031976', 'plastid thylakoid', 151, 'plasma membrane of ...'), ('CL_0002258', 'thyroid follicular cell', 174, 'thyroid follicular cells'), ('UBERON_0001746', 'capsule of thyroid gland', 174, 'thyroid follicular'), ('CHEBI_16382', 'iodide', 219, 'iodide'), ('UBERON_0002046', 'thyroid gland', 235, 'thyroid'), ('CHEBI_26710', 'sodium chloride', 295, 'Na,')]
PMC4089555	5/2014	S42-PMC4089555	['the oxidation of Iodide is mediated by Thyroid peroxidase (Tpo).']	N/A	N/A	[('CHEBI_16382', 'iodide', 17, 'iodide'), ('UBERON_0002046', 'thyroid gland', 39, 'thyroid'), ('PR_000016585', 'tripeptidyl-peptidase 1', 59, 'TPO')]
PMC4089555	5/2014	S49-PMC4089555	['this allows the re-utilization of Iodide within the Thyroid Cell [27].']	N/A	N/A	[('CHEBI_16382', 'iodide', 34, 'iodide'), ('CL_0000893', 'thymocyte', 52, 'thyroid cell'), ('UBERON_0002046', 'thyroid gland', 52, 'thyroid')]
PMC4089555	5/2014	S56-PMC4089555	['1) tsh\ntsh stimulates Thyroid Hormone Synthesis and secretion.']	N/A	N/A	[('CHEBI_60311', 'thyroid hormone', 22, 'thyroid hormone'), ('GO_0042412', 'taurine biosynthetic process', 22, 'thyroid hormone synthesis'), ('UBERON_0002046', 'thyroid gland', 22, 'thyroid')]
PMC4089555	5/2014	S77-PMC4089555	['Iodide-trapping defect with little or no uptake of radioactive Iodide both at the Thyroid and Salivary Gland levelperchlorate, Thiocyanate and Nitratesincreased risk of goiter development and hypothyroidism, specially in Iodine deficient populationsgoitrogens (Soy and other Flavonoids, Glucosinolates and Cyanogenic Glucosides)increased risk of goiter development and hypothyroidism in Iodine deficient populationsapical Iodide effluxpendred syndrome.']	N/A	N/A	[('CHEBI_5859', 'Icacine', 0, 'Iodide'), ('CHEBI_16382', 'iodide', 63, 'iodide'), ('UBERON_0002046', 'thyroid gland', 82, 'thyroid'), ('UBERON_0001044', 'saliva-secreting gland', 94, 'salivary gland'), ('CHEBI_18022', 'thiocyanate', 127, 'thiocyanate'), ('CHEBI_52171', 'hydrabamine(2+)', 143, 'nitratesIncreased'), ('CHEBI_24859', 'iodine atom', 221, 'iodine'), ('CHEBI_29922', 'sulfo group', 261, 'soy'), ('CHEBI_72544', 'flavonoids', 275, 'flavonoids'), ('CHEBI_24301', 'glucuronolactone', 287, 'glucosinolates'), ('CHEBI_36960', 'carbonothioic acid', 306, 'cyanogenic glucosides'), ('CHEBI_24859', 'iodine atom', 387, 'iodine'), ('CHEBI_16382', 'iodide', 422, 'iodide')]
PMC4089555	5/2014	S95-PMC4089555	['affected Individuals have an Iodide-trapping defect with little or no uptake of radioactive Iodide both in the Thyroid and the Salivary Glands [69].']	N/A	N/A	[('NCBITaxon_1', 'root', 9, 'individuals'), ('CHEBI_16382', 'iodide', 29, 'iodide'), ('CHEBI_16382', 'iodide', 92, 'iodide'), ('UBERON_0002046', 'thyroid gland', 111, 'thyroid'), ('UBERON_0001044', 'saliva-secreting gland', 127, 'salivary glands')]
PMC4089555	5/2014	S109-PMC4089555	['both duox Genes are Expressed in the Thyroid but their Expression is not restricted to the Thyroid.']	N/A	N/A	[('SO_0000704', 'gene', 10, 'genes'), ('GO_0010467', 'gene expression', 20, 'expressed'), ('UBERON_0002046', 'thyroid gland', 37, 'thyroid'), ('GO_0010467', 'gene expression', 55, 'expression'), ('UBERON_0002046', 'thyroid gland', 91, 'thyroid')]
PMC4089555	5/2014	S120-PMC4089555	['the clinical spectrum ranges from normal Thyroid function to overt hypothyroidism.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 41, 'thyroid')]
PMC4089555	5/2014	S129-PMC4089555	['in graves’ disease, the Production Of Tshr-stimulating Immunoglobulins causes increased Thyroid Cell Proliferation, Iodide Uptake and Thyroid Hormone Synthesis.']	N/A	N/A	[('GO_0006606', 'protein import into nucleus', 24, 'production of ... immunoglobulins'), ('PR_000016671', 'thyroid receptor-interacting protein 11', 38, 'TSHR'), ('GO_0019814', 'immunoglobulin complex', 55, 'immunoglobulins'), ('CL_0000893', 'thymocyte', 88, 'thyroid cell'), ('UBERON_0002046', 'thyroid gland', 88, 'thyroid'), ('GO_0008283', 'cell proliferation', 96, 'cell proliferation'), ('CHEBI_16382', 'iodide', 116, 'iodide'), ('GO_0098657', 'import into cell', 123, 'uptake'), ('CHEBI_60311', 'thyroid hormone', 134, 'thyroid hormone'), ('GO_0042412', 'taurine biosynthetic process', 134, 'thyroid hormone synthesis'), ('UBERON_0002046', 'thyroid gland', 134, 'thyroid')]
PMC4089555	5/2014	S134-PMC4089555	['during Pregnancy, Hcg stimulates Iodide Transport and Thyroid Hormone Synthesis through stimulation of the Tshr.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 7, 'pregnancy'), ('CHEBI_16568', '5,10-methylenetetrahydromethanopterin', 18, 'hCG'), ('CHEBI_16382', 'iodide', 33, 'iodide'), ('GO_0006811', 'ion transport', 33, 'iodide transport'), ('CHEBI_60311', 'thyroid hormone', 54, 'thyroid hormone'), ('GO_0042412', 'taurine biosynthetic process', 54, 'thyroid hormone synthesis'), ('UBERON_0002046', 'thyroid gland', 54, 'thyroid'), ('PR_000016671', 'thyroid receptor-interacting protein 11', 107, 'TSHR')]
PMC4089555	5/2014	S158-PMC4089555	['inactive forms of Thyroid hormone.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 18, 'thyroid')]
PMC4089555	5/2014	S184-PMC4089555	['2) medications used to treat hyperthyroidism\nthe Anti-Thyroid Drugs used in the us include Propyl-Thiouracil (6-Propyl-2-Thiouracil) and Methimazole (1-Methyl-2-Mercaptoimidazole).']	N/A	N/A	[('CHEBI_35472', 'anti-inflammatory drug', 49, 'anti-thyroid drugs'), ('UBERON_0002046', 'thyroid gland', 54, 'thyroid'), ('CHEBI_8474', 'propane-2-thiol', 91, 'propyl-thiouracil'), ('CHEBI_8502', '6-propyl-2-thiouracil', 110, '6-propyl-2-thiouracil'), ('CHEBI_50673', 'methimazole', 137, 'methimazole'), ('CHEBI_60333', '1-erythrosylbenzimidazole', 150, '1-methyl-2-mercaptoimidazole')]
PMC4089555	5/2014	S186-PMC4089555	['these Thionamide Drugs are actively concentrated in the Thyroid and their primary effect consists in inhibiting the Tpo-mediated organification [124].']	N/A	N/A	[('CHEBI_38500', 'EC 1.9.3.1 (cytochrome c oxidase) inhibitor', 6, 'thionamide'), ('CHEBI_23888', 'drug', 17, 'drugs'), ('UBERON_0002046', 'thyroid gland', 56, 'thyroid'), ('PR_000016585', 'tripeptidyl-peptidase 1', 116, 'TPO')]
PMC4089555	5/2014	S189-PMC4089555	['both, Glucosinolates and Cyanogenic Glucosides are Metabolized to Thiocyanate that competes for Thyroid Iodide uptake.']	N/A	N/A	[('CHEBI_24301', 'glucuronolactone', 6, 'glucosinolates'), ('CHEBI_36960', 'carbonothioic acid', 25, 'cyanogenic glucosides'), ('GO_0008152', 'metabolic process', 51, 'metabolized'), ('CHEBI_18022', 'thiocyanate', 66, 'thiocyanate'), ('CHEBI_50886', 'tin disulfide', 96, 'thyroid iodide'), ('UBERON_0002046', 'thyroid gland', 96, 'thyroid')]
PMC4089555	5/2014	S194-PMC4089555	['Iodine as a tool for diagnosis and treatment of Thyroid disorders\nthe ability of the Thyroid to concentrate Iodide is widely used in the diagnosis and treatment of Thyroid disorders.']	N/A	N/A	[('CHEBI_31719', 'ipriflavone', 0, 'Iodine'), ('UBERON_0002046', 'thyroid gland', 48, 'thyroid'), ('UBERON_0002046', 'thyroid gland', 85, 'thyroid'), ('CHEBI_16382', 'iodide', 108, 'iodide'), ('UBERON_0002046', 'thyroid gland', 164, 'thyroid')]
PMC4089555	5/2014	S198-PMC4089555	['graves’ disease, toxic nodules), from an underactive Thyroid with decreased Iodine uptake, secondary to either Thyroid damage or inactivation (e.g.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 53, 'thyroid'), ('CHEBI_24859', 'iodine atom', 76, 'iodine'), ('UBERON_0002046', 'thyroid gland', 111, 'thyroid')]
PMC4089555	5/2014	S199-PMC4089555	['thyroiditis, factitious thyrotoxicosis) or a blockade in Thyroid Uptake (e.g.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 57, 'thyroid'), ('GO_0098657', 'import into cell', 65, 'uptake')]
PMC4089555	5/2014	S201-PMC4089555	['whole body scans with radioactive Iodine are useful for the staging and planning of therapy of well-differentiated Thyroid cancer [129].']	N/A	N/A	[('CHEBI_24859', 'iodine atom', 34, 'iodine'), ('UBERON_0002046', 'thyroid gland', 115, 'thyroid')]
PMC4089555	5/2014	S202-PMC4089555	['because of the ability of nis to transport Pertechnetate (tco4−),99Mtco4−, an Isotope with no β emission and a short half-life, can be used to image Thyroid Tissue (see table\xa03) [130-132].']	N/A	N/A	[('CHEBI_8024', 'perindopril', 43, 'pertechnetate'), ('CHEBI_63336', 'paratose', 65, '99mTcO4−,'), ('SO_0001017', 'silent_mutation', 78, 'isotope'), ('UBERON_0002046', 'thyroid gland', 149, 'thyroid'), ('UBERON_0000479', 'tissue', 157, 'tissue')]
PMC4089555	5/2014	S204-PMC4089555	['this test relies on the fact that Iodide transported into the Thyroid is covalently bound to tg (organification).']	N/A	N/A	[('CHEBI_16382', 'iodide', 34, 'iodide'), ('UBERON_0002046', 'thyroid gland', 62, 'thyroid')]
PMC4089555	5/2014	S211-PMC4089555	['new developments in Iodide Transport in the diagnosis and management of Thyroid cancer\npoorly differentiated Thyroid Cancer cells show decreased or absent Iodide Uptake.']	N/A	N/A	[('CHEBI_16382', 'iodide', 20, 'iodide'), ('GO_0006811', 'ion transport', 20, 'iodide transport'), ('UBERON_0002046', 'thyroid gland', 72, 'thyroid'), ('UBERON_0002046', 'thyroid gland', 109, 'thyroid'), ('CL_0000540', 'neuron', 117, 'cancer'), ('CHEBI_16382', 'iodide', 155, 'iodide'), ('GO_0098657', 'import into cell', 162, 'uptake')]
PMC4089555	5/2014	S233-PMC4089555	['his research interests include Genetic Endocrine disorders, in particular of the Thyroid and the Pituitary Gland.']	N/A	N/A	[('SO_0000704', 'gene', 31, 'genetic'), ('GO_0006397', 'mRNA processing', 39, 'endocrine'), ('UBERON_0002046', 'thyroid gland', 81, 'thyroid'), ('UBERON_0000007', 'pituitary gland', 97, 'pituitary gland')]
PMC4090565	6/2014	S51-PMC4090565	['excluding factors were twin Pregnancy, major congenital anomalies, Pregnancies complicated by maternal history of Cardiovascular disease or Endocrine disorders (diabetes, hypercholesterolemia, Preeclampsia, Thyroid, and Adrenal problems), and clinical chorioamnionitis.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 28, 'pregnancy'), ('GO_0007565', 'female pregnancy', 67, 'pregnancies'), ('UBERON_0004535', 'cardiovascular system', 114, 'cardiovascular'), ('GO_0006397', 'mRNA processing', 140, 'endocrine'), ('GO_0007128', 'meiotic prophase I', 193, 'preeclampsia'), ('UBERON_0002046', 'thyroid gland', 207, 'thyroid'), ('UBERON_0002369', 'adrenal gland', 220, 'adrenal')]
PMC4113768	7/2014	S2305-PMC4113768	['anthropometrics were obtained and fasting Blood samples were taken for ascertaining Lipid and Thyroid profile, as well as measuring pth, 25(Oh) Vitamin D and calcium.']	N/A	N/A	[('UBERON_0000178', 'blood', 42, 'blood'), ('CHEBI_18059', 'lipid', 84, 'lipid'), ('UBERON_0002046', 'thyroid gland', 94, 'thyroid'), ('CHEBI_30778', 'gallic acid', 137, '25(OH)'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D')]
PMC4122175	8/2014	S36-PMC4122175	['caption (fig): figure 1\n\nPregnant sprague dawley (s) and brown norway (b) dams differ in their Thyroid function and Thyroid hormonal response to Alcohol .']	N/A	N/A	[('GO_0007565', 'female pregnancy', 25, 'Pregnant'), ('UBERON_0002046', 'thyroid gland', 95, 'thyroid'), ('UBERON_0002046', 'thyroid gland', 116, 'thyroid'), ('CHEBI_30879', 'alcohol', 145, 'alcohol')]
PMC4122175	8/2014	S45-PMC4122175	['the t3/logtsh ratio was derived as a measure of Thyroid function.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 48, 'thyroid')]
PMC4122175	8/2014	S116-PMC4122175	['knowing this, we tracked maternal and paternal Expression of the maternally Imprinted Gene that encodes the Thyroid Metabolizing Enzyme Deiodinase 3 (Dio3) in several Brain Regions of the sb f1 Rat offspring (sittig et al.,2011b).']	N/A	N/A	[('GO_0010467', 'gene expression', 47, 'expression'), ('GO_0071514', 'genetic imprinting', 76, 'imprinted'), ('SO_0000704', 'gene', 86, 'gene'), ('GO_0007596', 'blood coagulation', 108, 'thyroid metabolizing'), ('PR_000016293', 'protein-glutamine gamma-glutamyltransferase 2', 108, 'thyroid metabolizing enzyme deiodinase 3'), ('UBERON_0002046', 'thyroid gland', 108, 'thyroid'), ('PR_000006480', 'type I iodothyronine deiodinase', 150, 'Dio3'), ('UBERON_0002616', 'regional part of brain', 167, 'brain regions'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 194, 'rat')]
PMC4169453	9/2014	S38-PMC4169453	['the exclusion criteria were: maternal and neonatal Endocrine disorders (e.g., diabetes mellitus, Thyroid disease, disturbed Calcium-Phosphorus Homeostasis), Renal and Hepatic insufficiency, Anticonvulsant treatment, and congenital malformations of the newborn infant.']	N/A	N/A	[('GO_0006397', 'mRNA processing', 51, 'endocrine'), ('UBERON_0002046', 'thyroid gland', 97, 'thyroid'), ('CHEBI_22313', 'alkaline earth metal atom', 124, 'calcium'), ('GO_0055073', 'cadmium ion homeostasis', 124, 'calcium- ... homeostasis'), ('CHEBI_35885', 'secondary phosphine', 132, 'phosphorus'), ('UBERON_0002113', 'kidney', 157, 'renal'), ('UBERON_0002107', 'liver', 167, 'hepatic'), ('CHEBI_35624', 'azaspiro compound', 190, 'anticonvulsant')]
PMC4208652	6/2014	S169-PMC4208652	['Dna Methylation suppresses the Expression of Thyroid Transcription Factor‐1 (Ttf‐1) in 60% of undifferentiated Thyroid carcinomas (kondo et al.2009).']	N/A	N/A	[('GO_0006306', 'DNA methylation', 0, 'DNA methylation'), ('GO_0010467', 'gene expression', 31, 'expression'), ('PR_000016180', 'transcription factor 21', 45, 'thyroid transcription factor‐1'), ('UBERON_0002046', 'thyroid gland', 45, 'thyroid'), ('PR_000016771', 'testis-specific serine/threonine-protein kinase 2', 77, 'TTF‐1'), ('UBERON_0002046', 'thyroid gland', 111, 'thyroid')]
PMC4224261	9/2014	S83-PMC4224261	['Iodine Metabolism in the Pregnant versus the non-Pregnant state\nInorganic Iodine is almost completely absorbed from the Gastrointestinal Tract [15], and Plasma inorganic Iodine is primarily balanced by Iodine Intake, Transfer Of Iodine into the Thyroid Gland and Renal Excretion Of Iodine.']	N/A	N/A	[('CHEBI_31719', 'ipriflavone', 0, 'Iodine'), ('GO_0046102', 'inosine metabolic process', 0, 'Iodine Metabolism'), ('GO_0007565', 'female pregnancy', 25, 'Pregnant'), ('GO_0007565', 'female pregnancy', 49, 'Pregnant'), ('CHEBI_5939', 'Interferon gamma-1b', 64, 'Inorganic'), ('CHEBI_24859', 'iodine atom', 74, 'iodine'), ('UBERON_0001555', 'digestive tract', 120, 'gastrointestinal tract'), ('UBERON_0001969', 'blood plasma', 153, 'plasma'), ('CHEBI_24859', 'iodine atom', 170, 'iodine'), ('CHEBI_24859', 'iodine atom', 202, 'iodine'), ('GO_0007631', 'feeding behavior', 209, 'intake'), ('GO_0009294', 'DNA mediated transformation', 217, 'transfer of iodine'), ('CHEBI_24859', 'iodine atom', 229, 'iodine'), ('UBERON_0002046', 'thyroid gland', 245, 'thyroid gland'), ('GO_0006281', 'DNA repair', 263, 'renal'), ('UBERON_0002113', 'kidney', 263, 'renal'), ('GO_0008386', 'cholesterol monooxygenase (side-chain-cleaving) activity', 269, 'excretion of iodine'), ('CHEBI_24859', 'iodine atom', 282, 'iodine')]
PMC4224261	9/2014	S103-PMC4224261	['uic in Pregnant women versus male partners\nthe mandatory Iodine fortification of Salt was introduced in denmark in the year 2000, and the danish investigation of Iodine intake and Thyroid disease (danthyr) has monitored the Iodine Excretion in two regions of denmark with a different Iodine Intake before the Iodine fortification (moderate vs. mild Iodine deficiency) [10].']	N/A	N/A	[('GO_0007565', 'female pregnancy', 7, 'Pregnant'), ('CHEBI_24859', 'iodine atom', 57, 'iodine'), ('CHEBI_24866', 'salt', 81, 'salt'), ('CHEBI_24859', 'iodine atom', 162, 'iodine'), ('UBERON_0002046', 'thyroid gland', 180, 'thyroid'), ('CHEBI_24859', 'iodine atom', 224, 'iodine'), ('GO_0007588', 'excretion', 231, 'excretion'), ('CHEBI_24859', 'iodine atom', 284, 'iodine'), ('GO_0007631', 'feeding behavior', 291, 'intake'), ('CHEBI_24859', 'iodine atom', 309, 'iodine'), ('CHEBI_24859', 'iodine atom', 349, 'iodine')]
PMC4251881	11/2014	S74-PMC4251881	['those Pregnant women with preexisting Autoimmune diseases have a variable course, with some improving during Pregnancy (i.e., ra, ms, and Thyroid dz) and some flaring (i.e., sle) [9].']	N/A	N/A	[('GO_0007565', 'female pregnancy', 6, 'pregnant'), ('UBERON_0001442', 'skeleton of manus', 38, 'autoimmune'), ('GO_0007565', 'female pregnancy', 109, 'pregnancy'), ('UBERON_0002046', 'thyroid gland', 138, 'thyroid')]
PMC4302388	1/2015	S31-PMC4302388	['women were excluded if they were under 18 years, current smokers, taking any supplement containing Se, taking Thyroid medication, had a multi-fetal Pregnancy or a number of other specified Pregnancy complications, or withheld consent.']	N/A	N/A	[('CHEBI_37972', 'phosphorus-32 atom', 99, 'Se'), ('UBERON_0002046', 'thyroid gland', 110, 'thyroid'), ('GO_0007565', 'female pregnancy', 148, 'pregnancy'), ('GO_0007565', 'female pregnancy', 189, 'pregnancy')]
PMC4311629	1/2015	S77-PMC4311629	['Bat Activation by cold exposure, β3-Agonist or Thyroid Hormone treatment was shown to improve Glucose tolerance and Insulin sensitivity (cawthorne et al.,1984; forest et al.,1987; peirce and vidal-puig,2013).']	N/A	N/A	[('UBERON_0001348', 'brown adipose tissue', 0, 'BAT'), ('GO_0045148', 'tripeptide aminopeptidase activity', 4, 'activation'), ('CHEBI_85384', 'GABA reuptake inhibitor', 36, 'agonist'), ('CHEBI_60311', 'thyroid hormone', 47, 'thyroid hormone'), ('UBERON_0002046', 'thyroid gland', 47, 'thyroid'), ('CHEBI_17234', 'glucose', 94, 'glucose'), ('PR_000045358', 'insulin family protein', 116, 'insulin')]
PMC4311629	1/2015	S119-PMC4311629	['in Humans, a unique patient suffering from extreme diabetes due to a mutation in the Insulin Receptor Gene had to undergo total Thyroidectomy because of the presence of a papillary carcinoma.']	N/A	N/A	[('NCBITaxon_9606', 'Homo sapiens', 3, 'humans'), ('PR_000001365', 'interleukin-10 receptor subunit alpha', 85, 'insulin receptor'), ('SO_0000704', 'gene', 102, 'gene'), ('UBERON_0002046', 'thyroid gland', 128, 'thyroidectomy')]
PMC4383437	3/2015	S52-PMC4383437	['medical and obstetric history variables relevant to the tested outcomes were combined into an obstetric/fetal risk factor variable, which included history of Kidney disease; hypertension; anemia; Heart disease; seizures; diabetes; hiv; Rh negative status; asthma; Sexually Transmitted infections; abnormal Blood Clotting; Thyroid disorders; Vaginal, Cervical, or Urinary Tract infections; Endocrine disorders; abnormal Pregnancy weight gain (<4\u2009kg or >18\u2009kg); Preeclampsia; or abnormal bleeding during Pregnancy.']	N/A	N/A	[('UBERON_0002113', 'kidney', 158, 'kidney'), ('UBERON_0000948', 'heart', 196, 'heart'), ('PR_000013773', 'retinoblastoma-associated protein', 236, 'Rh'), ('GO_0019095', 'pole plasm mitochondrial rRNA localization', 264, 'sexually transmitted'), ('GO_0007596', 'blood coagulation', 306, 'blood clotting'), ('UBERON_0000178', 'blood', 306, 'blood'), ('UBERON_0002046', 'thyroid gland', 322, 'thyroid'), ('UBERON_0001987', 'placenta', 341, 'vaginal'), ('UBERON_0005434', 'cervical region', 350, 'cervical'), ('UBERON_0001553', 'medial tarsal artery', 363, 'urinary tract'), ('GO_0006397', 'mRNA processing', 389, 'endocrine'), ('UBERON_0002049', 'vasculature', 389, 'endocrine'), ('GO_0007565', 'female pregnancy', 419, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 460, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 502, 'pregnancy')]
PMC4392553	3/2015	S39-PMC4392553	['furthermore, many other biologically active Molecules, including Serotonin, melatonin, Melanin, Epinephrine, Dopamine, Thyroid hormone, Folate, coenzyme q10, Vitamin K, and Vitamin E, depend on the shikimate pathway Metabolites as precursors.']	N/A	N/A	[('CHEBI_36357', 'polyatomic entity', 44, 'molecules'), ('CHEBI_28790', 'serotonin', 65, 'serotonin'), ('CHEBI_25179', 'melanins', 87, 'melanin'), ('CHEBI_48509', 'triflic anhydride', 96, 'epinephrine'), ('CHEBI_18243', 'dopamine', 109, 'dopamine'), ('UBERON_0002046', 'thyroid gland', 119, 'thyroid'), ('CHEBI_30863', '5-azaorotic acid', 136, 'folate'), ('CHEBI_27300', 'vitamin D', 158, 'vitamin K'), ('CHEBI_27300', 'vitamin D', 173, 'vitamin E'), ('CHEBI_25212', 'metabolite', 216, 'metabolites')]
PMC4392553	3/2015	S518-PMC4392553	['[238]\n\ncaption (fig): figure 7\n\nplots of Glyphosate usage on corn and soy crops (blue), percent of corn and soy that is Genetically engineered to be “roundup ready” (red), and incidence of Thyroid cancer (yellow bars) in the us.']	N/A	N/A	[('CHEBI_17754', 'glycerol', 41, 'glyphosate'), ('SO_0000704', 'gene', 120, 'genetically'), ('UBERON_0002046', 'thyroid gland', 189, 'thyroid')]
PMC4392553	3/2015	S599-PMC4392553	['these include autism, ad, pd, anxiety disorder, osteoporosis, Inflammatory Bowel disease, Renal lithiasis, osteomalacia, cholestasis, Thyroid dysfunction, and infertility.']	N/A	N/A	[('UBERON_0001782', 'pigmented layer of retina', 62, 'inflammatory bowel'), ('UBERON_0002113', 'kidney', 90, 'renal'), ('UBERON_0002046', 'thyroid gland', 134, 'thyroid')]
PMC4441812	6/2015	S36-PMC4441812	['among other exclusion criteria (14), women were not eligible if they were current smokers, taking Thyroid medication, or taking a Selenium-containing supplement.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 98, 'thyroid'), ('CHEBI_27568', 'selenium atom', 130, 'selenium')]
PMC4499266	4/2015	S73-PMC4499266	['pendred syndrome\nthis is an Autosomal recessive syndrome with symptoms such as sensorineural Hearing loss andpartially defective Iodine organification, a process of adding Iodine to thyroglobin for the production of Thyroid hormone[25].']	N/A	N/A	[('GO_0030849', 'autosome', 28, 'autosomal'), ('GO_0007605', 'sensory perception of sound', 93, 'hearing'), ('CHEBI_24859', 'iodine atom', 129, 'iodine'), ('CHEBI_24859', 'iodine atom', 172, 'iodine'), ('UBERON_0002046', 'thyroid gland', 216, 'thyroid')]
PMC4499266	4/2015	S77-PMC4499266	['Pendrin functions as an Anion exchanger and is Expressed in the Kidney, Thyroid and Inner Ear.']	N/A	N/A	[('PR_000015039', 'pendrin', 0, 'Pendrin'), ('CHEBI_22563', 'anion', 24, 'anion'), ('GO_0010467', 'gene expression', 47, 'expressed'), ('UBERON_0002113', 'kidney', 64, 'kidney'), ('UBERON_0002046', 'thyroid gland', 72, 'thyroid'), ('UBERON_0001846', 'internal ear', 84, 'inner ear')]
PMC4661500	11/2014	S2-PMC4661500	['Vascularization indices were elevated in cases of newly diagnosed benign Thyroid diseases.']	N/A	N/A	[('GO_0008104', 'protein localization', 0, 'Vascularization'), ('UBERON_0002046', 'thyroid gland', 73, 'thyroid')]
PMC4661500	11/2014	S25-PMC4661500	['3d-perfusion patterns of the Thyroid are responsive to Magnesium supplementation.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 29, 'thyroid'), ('CHEBI_22313', 'alkaline earth metal atom', 55, 'magnesium')]
PMC4661500	11/2014	S27-PMC4661500	['increased Thyroid perfusion in the first days after in-vitro Fertilization.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 10, 'thyroid'), ('GO_0009566', 'fertilization', 61, 'fertilization')]
PMC4661500	11/2014	S42-PMC4661500	['at the time this study on Micronutrients was being carried out we started to supplement Thyroid disease patients only with Selenomethionine[12].']	N/A	N/A	[('CHEBI_33839', 'macromolecule', 26, 'micronutrients'), ('UBERON_0002046', 'thyroid gland', 88, 'thyroid'), ('CHEBI_26630', 'selenocystathionine', 123, 'selenomethionine')]
PMC4661500	11/2014	S66-PMC4661500	['3-d quantitative power doppler Thyroid sonography\nthe 3-dimensional quantitative power doppler sonography of the Thyroid was done as described recently by us[16].']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 31, 'thyroid'), ('UBERON_0002046', 'thyroid gland', 113, 'thyroid')]
PMC4661500	11/2014	S91-PMC4661500	['this set of patients included 15 controls (10 females), 51 menopausal women, 15 patients with Thyroid disorders (14 females), 33 women with infertility, 17 patients with depression, and 25 patients with flu-like light Respiratory infections.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 94, 'thyroid'), ('UBERON_0001004', 'respiratory system', 218, 'respiratory')]
PMC4661500	11/2014	S99-PMC4661500	['results\n\nanalysis of magnesium levels according to sonography and laboratory results\nbased on the results of the ultrasound examination as well as on the Thyroid function tests we classified 48 subjects as having both normal Thyroid function tests as well as an uneventful morphology of the Thyroid (controls), 89 cases as hypothyroid, 24 cases as hyperthyroid, and 4 cases as presenting sub-acute thyroiditis.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 154, 'thyroid'), ('UBERON_0002046', 'thyroid gland', 225, 'thyroid'), ('UBERON_0002046', 'thyroid gland', 291, 'thyroid')]
PMC4661500	11/2014	S100-PMC4661500	['patients already being treated for Thyroid dysfunction included 5 with hyperthyroidism, and 6 with thyroiditis.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 35, 'thyroid')]
PMC4661500	11/2014	S110-PMC4661500	['analysis of the Thyroid quantitative 3d-power doppler sonography\nthe Vascularization index (vi) given in % was found lowest in normal subjects (mean 5.56\xa0±\xa02.9%).']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 16, 'thyroid'), ('GO_0001944', 'vasculature development', 69, 'vascularization')]
PMC4661500	11/2014	S128-PMC4661500	['Thyroid perfusion parameters and Thyroid serology\nall three Thyroid perfusion parameters were lower in patients with negative Thyroid serology as compared to patients with positive Thyroid serology (vi%: 10.7\xa0±\xa07.3 vs. 25.1\xa0±\xa016.6, fi: 36.8\xa0±\xa02.7 vs. 39.7\xa0±\xa03.4, vfi: 4.0\xa0±\xa02.8 vs. 10.5\xa0±\xa07.9).']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 0, 'Thyroid'), ('UBERON_0002046', 'thyroid gland', 33, 'thyroid'), ('UBERON_0002046', 'thyroid gland', 60, 'thyroid'), ('UBERON_0002046', 'thyroid gland', 126, 'thyroid'), ('UBERON_0002046', 'thyroid gland', 181, 'thyroid')]
PMC4661500	11/2014	S187-PMC4661500	['sequential Thyroid perfusion parameters in relation to hyperthyroidism, physical stress, psychological stress, and common flu\nwhile the majority of patients were examined three times, single sequential cases were followed closer and more often (up to 8 follow-up examinations).']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 11, 'thyroid')]
PMC4661500	11/2014	S200-PMC4661500	['following supplementation a clear improvement was seen together with normalization of Thyroid function.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 86, 'thyroid')]
PMC4661500	11/2014	S211-PMC4661500	['under the supplementation regimen a steady improvement in Thyroid function was observed.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 58, 'thyroid')]
PMC4661500	11/2014	S214-PMC4661500	['parallel to these Parenchymal changes the size of the Thyroid diminished significantly.']	N/A	N/A	[('UBERON_0001804', 'capsule of lens', 18, 'parenchymal'), ('UBERON_0002046', 'thyroid gland', 54, 'thyroid')]
PMC4661500	11/2014	S227-PMC4661500	['the third sibling was seen also in order to discard Thyroid disease.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 52, 'thyroid')]
PMC4661500	11/2014	S232-PMC4661500	['this triple approach brought a normalization of Thyroid function together with an improvement in the morphology of Thyroid vascularity (fig.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 48, 'thyroid'), ('UBERON_0002046', 'thyroid gland', 115, 'thyroid')]
PMC4661500	11/2014	S256-PMC4661500	['together with this biochemical alteration we document increased levels of vascularity within the Thyroid.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 97, 'thyroid')]
PMC4661500	11/2014	S355-PMC4661500	['experiments that aimed at interfering Oxidative Phosphorylation in Thyroid samples were conducted in 1955 by freinkel and ingbar[84],[85].']	N/A	N/A	[('GO_0006119', 'oxidative phosphorylation', 38, 'oxidative phosphorylation'), ('UBERON_0002046', 'thyroid gland', 67, 'thyroid')]
PMC4661500	11/2014	S356-PMC4661500	['using disruptors such as 2,4-Dinitrophenol or Cyanide the Iodide concentrating capacity of the Thyroid was lowered.']	N/A	N/A	[('CHEBI_42017', '2,4-dinitrophenol', 25, '2,4-dinitrophenol'), ('CHEBI_17514', 'cyanide', 46, 'cyanide'), ('CHEBI_16382', 'iodide', 58, 'iodide'), ('UBERON_0002046', 'thyroid gland', 95, 'thyroid')]
PMC4661500	11/2014	S375-PMC4661500	['in 1954 hoch and lipmann published a study entitled “the uncoupling of Respiration and phosphorylation by Thyroid Hormones”[92].']	N/A	N/A	[('GO_0045333', 'cellular respiration', 71, 'respiration'), ('CHEBI_26935', 'tetraterpenoid', 106, 'thyroid hormones'), ('UBERON_0002046', 'thyroid gland', 106, 'thyroid')]
PMC4661500	11/2014	S408-PMC4661500	['treatment of the corresponding Thyroid diseases normalized the Excretion values.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 31, 'thyroid'), ('GO_0007588', 'excretion', 63, 'excretion')]
PMC4661500	11/2014	S411-PMC4661500	['Mg++and Thyroid Hormones are antagonists in vivo and in vitro when Mitochondrial function is measured” (page 357 in[104]).']	N/A	N/A	[('CHEBI_29103', 'potassium(1+)', 0, 'Mg++'), ('CHEBI_26935', 'tetraterpenoid', 8, 'thyroid hormones'), ('UBERON_0002046', 'thyroid gland', 8, 'thyroid'), ('GO_0005739', 'mitochondrion', 67, 'mitochondrial')]
PMC4661500	11/2014	S458-PMC4661500	['patients with Thyroid diseases can have anti-myoglobin Antibodies in Blood[128],[130].']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 14, 'thyroid'), ('GO_0042571', 'immunoglobulin complex, circulating', 55, 'antibodies'), ('UBERON_0000178', 'blood', 69, 'blood')]
PMC4661500	11/2014	S532-PMC4661500	['muscle Repair belongs to the scope of action of Thyroid hormone[188],[189],[190],[191].']	N/A	N/A	[('GO_0006281', 'DNA repair', 7, 'repair'), ('CHEBI_9437', 'temoporfin', 48, 'thyroid'), ('UBERON_0002046', 'thyroid gland', 48, 'thyroid')]
PMC4661500	11/2014	S553-PMC4661500	['in turn Thyroid Hormones are effective on Mitochondrial biogenesis as well as on muscle Repair[209],[210],[211].']	N/A	N/A	[('CHEBI_26935', 'tetraterpenoid', 8, 'thyroid hormones'), ('UBERON_0002046', 'thyroid gland', 8, 'thyroid'), ('GO_0005739', 'mitochondrion', 42, 'mitochondrial'), ('GO_0006281', 'DNA repair', 88, 'repair')]
PMC4661500	11/2014	S578-PMC4661500	['the same applies to the studies on Thyroid hormones and Oxidative Phosphorylation (section\xa04.6).']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 35, 'thyroid'), ('GO_0006119', 'oxidative phosphorylation', 56, 'oxidative phosphorylation')]
PMC4661500	11/2014	S657-PMC4661500	['this condition leads to increased Production Of Thyroid Hormones Triiodothyronine (preferentially) and Thyroxine in order to induce muscle Repair.fig.']	N/A	N/A	[('GO_0030154', 'cell differentiation', 34, 'production of thyroid hormones'), ('CHEBI_26935', 'tetraterpenoid', 48, 'thyroid hormones'), ('UBERON_0002046', 'thyroid gland', 48, 'thyroid'), ('CHEBI_26982', 'threo-3-methylmalic acid', 65, 'triiodothyronine'), ('CHEBI_17842', 'trypanothione', 103, 'thyroxine'), ('GO_0006281', 'DNA repair', 139, 'repair')]
PMC4661500	11/2014	S659-PMC4661500	['abbreviations\nvi\nvascularization indexfi\nflow indexvfi\nvascularization and flow indextrpm\ntransient Receptor Potential Melastatinivf\nin vitro-Fertilizationtao\nThyroid associated ophthalmopathyak\napplied kinesiologytcm\ntraditional Chinese Medicineoxphos\nOxidative Phosphorylation\n\ndisclosures\nrm and hm work as a team.']	N/A	N/A	[('PR_000004221', 'Rho GTPase-activating protein 12', 100, 'receptor potential melastatinIVF'), ('GO_0032508', 'DNA duplex unwinding', 142, 'fertilizationTAO'), ('UBERON_0002046', 'thyroid gland', 159, 'thyroid'), ('CHEBI_37130', 'caeside', 230, 'Chinese'), ('CHEBI_6796', 'Metarhodopsin', 238, 'MedicineOXPHOS'), ('GO_0006119', 'oxidative phosphorylation', 253, 'oxidative phosphorylation')]
PMC4661500	11/2014	S670-PMC4661500	['obscure origin of benign non-nodular Thyroid disease.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 37, 'thyroid')]
PMC4661500	11/2014	S676-PMC4661500	['reversibility of morphological changes in the Thyroid after supplementation.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 46, 'thyroid')]
PMC4661500	11/2014	S679-PMC4661500	['increased Thyroid perfusion in the first days after in-vitro Fertilization and egg transfer.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 10, 'thyroid'), ('GO_0009566', 'fertilization', 61, 'fertilization')]
PMC4661586	4/2015	S72-PMC4661586	['Thyroid function, obstetrical pathology, and Cognitive Development — early studies\nin 1960 greenman et al.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 0, 'Thyroid'), ('GO_0050787', 'detoxification of mercury ion', 45, 'cognitive development')]
PMC4661586	4/2015	S74-PMC4661586	['they included 22 women divided into 4 groups with known or suspected Thyroid disorders during 23 Pregnancies.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 69, 'thyroid'), ('GO_0007565', 'female pregnancy', 97, 'pregnancies')]
PMC4661586	4/2015	S75-PMC4661586	['in seven cases hypothyroidism was due to previous Thyroidectomy.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 50, 'thyroidectomy')]
PMC4661586	4/2015	S96-PMC4661586	['new guinea and the Man-made Iodine deficiency condition\nthe mention of new guinea as the setting for studying conditions of Thyroid disease deserves an extra comment.']	N/A	N/A	[('NCBITaxon_40674', 'Mammalia', 19, 'man'), ('CHEBI_24859', 'iodine atom', 28, 'iodine'), ('UBERON_0002046', 'thyroid gland', 124, 'thyroid')]
PMC4661586	4/2015	S149-PMC4661586	['after the days of bei determinations the way to detect altered Thyroid function in Pregnant women is through validated laboratory reference values.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 63, 'thyroid'), ('GO_0007565', 'female pregnancy', 83, 'pregnant')]
PMC4661586	4/2015	S158-PMC4661586	['to close this section we will briefly describe the results of an interventional study entitled: “antenatal Thyroid screening and childhood Cognitive function”[48].']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 107, 'thyroid'), ('GO_0050890', 'cognition', 139, 'cognitive')]
PMC4661586	4/2015	S337-PMC4661586	['in addition to this, Thyroid Hormones Regulate reelin Expression and thus Neuronal Migration[170].']	N/A	N/A	[('CHEBI_26935', 'tetraterpenoid', 21, 'thyroid hormones'), ('UBERON_0002046', 'thyroid gland', 21, 'thyroid'), ('GO_0065007', 'biological regulation', 38, 'regulate'), ('GO_0010467', 'gene expression', 54, 'expression'), ('CL_0000540', 'neuron', 74, 'neuronal'), ('GO_0001764', 'neuron migration', 74, 'neuronal migration')]
PMC4661586	4/2015	S349-PMC4661586	['in cases of hyperthyroidism as well as of hypothyroidism Thyroid morphology returned to normal after long-time supplementation with Magnesium Citrate, i.e.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 57, 'thyroid'), ('CHEBI_63006', 'magnesium formate dihydrate', 132, 'magnesium citrate')]
PMC4666222	11/2015	S42-PMC4666222	['hemoglobin and hematocrit were 9.5\xa0g/dl and 28.5\xa0% respectively, White Blood Cell count was 8.9\xa0×\xa0103/μl and Thyroid Stimulating Hormone was 1.28\xa0uiu/ml.']	N/A	N/A	[('CL_0000738', 'leukocyte', 65, 'white blood cell'), ('UBERON_0000178', 'blood', 71, 'blood'), ('CHEBI_75182', 'tolylfluanid', 109, 'thyroid stimulating hormone'), ('UBERON_0002046', 'thyroid gland', 109, 'thyroid')]
PMC4675066	12/2015	S2-PMC4675066	['secondary outcomes included Pregnancy outcomes, maternal Thyroid function and general health.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 28, 'pregnancy'), ('UBERON_0002046', 'thyroid gland', 57, 'thyroid')]
PMC4675066	12/2015	S5-PMC4675066	['Iodine status and Thyroid function were assessed at baseline and at 36\xa0weeks’ Gestation.']	N/A	N/A	[('CHEBI_31719', 'ipriflavone', 0, 'Iodine'), ('UBERON_0002046', 'thyroid gland', 18, 'thyroid'), ('GO_0007565', 'female pregnancy', 78, 'gestation')]
PMC4675066	12/2015	S33-PMC4675066	['women were excluded if they were taking a supplement containing Iodine, had a history of Thyroid disease or Drug or alcohol abuse, their fetus had a known major abnormality, or if english was not the main language spoken at home.']	N/A	N/A	[('CHEBI_24859', 'iodine atom', 64, 'iodine'), ('UBERON_0002046', 'thyroid gland', 89, 'thyroid'), ('CHEBI_23888', 'drug', 108, 'drug')]
PMC4675066	12/2015	S51-PMC4675066	['Iodine status and Thyroid function\nat study entry and 36\xa0weeks’ Gestation, women were asked to collect a spot Urine sample to assess Urinary Iodine concentration (uic).']	N/A	N/A	[('CHEBI_31719', 'ipriflavone', 0, 'Iodine'), ('UBERON_0002046', 'thyroid gland', 18, 'thyroid'), ('GO_0007565', 'female pregnancy', 64, 'gestation'), ('UBERON_0001088', 'urine', 110, 'urine'), ('UBERON_0001088', 'urine', 133, 'urinary'), ('CHEBI_24859', 'iodine atom', 141, 'iodine')]
PMC4675066	12/2015	S53-PMC4675066	['a Blood sample was also collected at baseline by venepuncture to assess Thyroid Hormone concentrations, including Thyroid-Stimulating Hormone (Tsh), thyroglobulin (tg), free Triiodothyronine (ft3) and free Thyroxine (ft4).']	N/A	N/A	[('UBERON_0000178', 'blood', 2, 'blood'), ('CHEBI_60311', 'thyroid hormone', 72, 'thyroid hormone'), ('UBERON_0002046', 'thyroid gland', 72, 'thyroid'), ('CHEBI_9437', 'temoporfin', 114, 'thyroid'), ('UBERON_0002046', 'thyroid gland', 114, 'thyroid'), ('CHEBI_66524', 'streptokordin', 122, 'stimulating hormone'), ('CHEBI_17855', 'triglyceride', 143, 'TSH'), ('CHEBI_26982', 'threo-3-methylmalic acid', 174, 'triiodothyronine'), ('CHEBI_17842', 'trypanothione', 206, 'thyroxine')]
PMC4675066	12/2015	S54-PMC4675066	['Thyroid function of newborns was also assessed from Cord Blood (tsh, ft3, ft4 and tg) and from newborn screening (tsh only).']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 0, 'Thyroid'), ('UBERON_0002240', 'spinal cord', 52, 'cord'), ('UBERON_0000178', 'blood', 57, 'blood')]
PMC4675066	12/2015	S91-PMC4675066	['caption (table-wrap): table 2\n\ndevelopmental outcomes from the bayley scales of infant and Toddler Development (bayley-iii)outcomeiodine ( n \u2009=\u200927)Placebo ( n \u2009=\u200926)treatment effect (95\xa0% ci) p valuecognitive standardised scorea99.4 (12.2)101.7 (8.2)−2.3 (−7.8, 3.2)0.42language standardised scorea97.2 (12.2)97.9 (11.5)−0.7 (−7.0, 5.6)0.83motor standardised scorea93.9 (10.8)92.4 (9.7)1.4 (−4.0, 6.9)0.61social-emotional standardised scorea105.8 (15.9)105.4 (16.2)0.4 (−8.5, 9.3)0.93adaptive behaviour standardised scorea105.2 (15.2)103.5 (14.9)1.8 (−6.4, 10.0)0.67cognitive scoreb<851 (3.7)0 (0.0)n/a>0.99cognitive scoreb<701 (3.7)0 (0.0)n/a>0.99language scoreb<853 (11.1)3 (11.5)n/a>0.99language scoreb<700 (0.0)0 (0.0)n/an/amotor scoreb<852 (7.4)5 (19.2)n/a0.25motor scoreb<701 (3.7)0 (0.0)n/a>0.99\nci confidence interval, n/a not applicable\nathe data are presented as mean (standard deviation), and the treatment effect is the difference in means\nbthe data are presented as number (percentage)\n\nIodine status and Thyroid function of mothers and infants\nthe median (interquartile range) uics of women at baseline (15\xa0weeks’ Gestation) and at 36\xa0weeks’ Gestation are shown in fig.']	N/A	N/A	[('GO_0001822', 'kidney development', 91, 'Toddler Development'), ('CHEBI_8246', 'Pirbuterol acetate', 147, 'Placebo'), ('CHEBI_31719', 'ipriflavone', 1000, 'Iodine'), ('UBERON_0002046', 'thyroid gland', 1018, 'thyroid'), ('GO_0007565', 'female pregnancy', 1128, 'gestation'), ('GO_0007565', 'female pregnancy', 1156, 'gestation')]
PMC4675066	12/2015	S99-PMC4675066	['ga Gestational age\n\ncaption (table-wrap): table 3\n\nbiomarkers of Iodine statusiodineplaceboeffect (95\xa0% ci) p valuecord Blood n \u2009=\u200919 n \u2009=\u200922free Triiodothyronine, pmol/la2.3 (0.4)2.3 (0.6)0.0 (−0.4, 0.3)0.81free Thyroxine, pmol/la14.4 (2.1)13.8 (2.3)0.6 (−0.9, 2.2)0.40thyroid-stimulating hormone, miu/lb8.2 (5.9–13.5)6.6 (4.5–9.6)n/a0.25thyroglobulin, μg/lb73.0 (48.0–100.0)64.0 (44.0–121.0)n/a0.66(n\u2009=\u200928)(n\u2009=\u200929)newborn tsh, miu/la2.1 (1.0)2.2 (1.2)−0.1 (−0.7, 0.5)0.79newborn tsh\u2009>\u20095c0 (0.0)0 (0.0)n/an/a(n\u2009=\u200920)(n\u2009=\u200925)Breast milk Iodine at 6\xa0weeks’ post-Partum, μg/lb106.0 (84.0–146.0)124.0 (76.0–155.0)n/a0.74\nci confidence interval, n/a not applicable, Tsh Thyroid-Stimulating Hormone\nadata are presented as mean (standard deviation), and the treatment effect is the difference in means\nbdata are presented as median (interquartile range)\ncdata are presented as number (percentage)\n\nPregnancy and other clinical outcomes\nthe mean Birth weight, length, Head circumference and Gestational Age at Birth did not differ between the groups (table\xa04).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 3, 'gestational'), ('CHEBI_24859', 'iodine atom', 65, 'iodine'), ('UBERON_0000178', 'blood', 120, 'blood'), ('CHEBI_26982', 'threo-3-methylmalic acid', 146, 'triiodothyronine'), ('CHEBI_17842', 'trypanothione', 213, 'thyroxine'), ('UBERON_0000310', 'breast', 525, 'Breast'), ('CHEBI_24859', 'iodine atom', 537, 'iodine'), ('GO_0007567', 'parturition', 561, 'partum'), ('PR_000016711', 'TSC22 domain family protein 1', 662, 'TSH'), ('CHEBI_9437', 'temoporfin', 666, 'thyroid'), ('UBERON_0002046', 'thyroid gland', 666, 'thyroid'), ('PR_000004775', 'BMP-binding endothelial regulator protein', 673, '-stimulating hormone'), ('CHEBI_66524', 'streptokordin', 674, 'stimulating hormone'), ('GO_0007565', 'female pregnancy', 892, 'Pregnancy'), ('GO_0007567', 'parturition', 939, 'birth'), ('UBERON_0000033', 'head', 961, 'head'), ('GO_0007565', 'female pregnancy', 984, 'gestational age'), ('GO_0007567', 'parturition', 1003, 'birth')]
PMC4688224	7/2015	S11-PMC4688224	['the eligibility criteria at enrollment were: 1) 16±3 weeks Gestation, 2) ≥18 years old, 3) living in a home built before 1978, 4) no history of hiv infection, and 5) not taking any medications for seizure or Thyroid disorders.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 59, 'gestation'), ('UBERON_0002046', 'thyroid gland', 208, 'thyroid')]
PMC4730616	1/2016	S76-PMC4730616	['furthermore, Cord Blood will be used for the assessment of Plasma Lipids (Cholesterol, hdl, ldl, Triglycerides, Apolipoprotein a and B), Glucose, leptin and Thyroid function (tsh, ft4).']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 13, 'cord'), ('UBERON_0000178', 'blood', 18, 'blood'), ('UBERON_0001969', 'blood plasma', 59, 'plasma'), ('CHEBI_18059', 'lipid', 66, 'lipids'), ('CHEBI_16113', 'cholesterol', 74, 'cholesterol'), ('CHEBI_17855', 'triglyceride', 97, 'triglycerides'), ('CHEBI_39015', 'apolipoprotein', 112, 'Apolipoprotein'), ('PR_000000037', 'BMP receptor type-2', 133, 'B'), ('CHEBI_17234', 'glucose', 137, 'glucose'), ('UBERON_0002046', 'thyroid gland', 157, 'thyroid')]
PMC4785305	3/2016	S78-PMC4785305	['during this visit, eligibility criteria will be verified and Blood tests for 25(Oh)D level, calcium, phosphate, magnesium, creatinine and Thyroid stimulating hormone (Tsh) will be withdrawn.']	N/A	N/A	[('UBERON_0000178', 'blood', 61, 'blood'), ('CHEBI_71657', 'versiconol acetate', 77, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 83, 'D'), ('UBERON_0002046', 'thyroid gland', 138, 'thyroid'), ('CHEBI_17855', 'triglyceride', 167, 'TSH')]
PMC4785305	3/2016	S84-PMC4785305	['pth, Parathyroid hormone; tsh, Thyroid-Stimulating Hormone; us, ultrasound\n\neligibility criteria\ninclusion criteria:\nPregnant women Gestational age (ga) <14\u2005weeks at screening visit.i\nmiddle eastern origin; middle east countries as defined by the world bank (bahrain, egypt, iran, iraq, palestine, jordan, kuwait, lebanon, oman, qatar, saudi arabia, syria, the united arab emirates, yemen).45\n25(Oh)D level between 25 and 75\u2005nmol/l.']	N/A	N/A	[('UBERON_0001132', 'parathyroid gland', 5, 'parathyroid'), ('UBERON_0002046', 'thyroid gland', 31, 'thyroid'), ('CHEBI_66524', 'streptokordin', 39, 'stimulating hormone'), ('GO_0007565', 'female pregnancy', 117, 'Pregnant'), ('GO_0007565', 'female pregnancy', 132, 'gestational'), ('CHEBI_71657', 'versiconol acetate', 393, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 393, '25(OH)D')]
PMC4785305	3/2016	S92-PMC4785305	['uncontrolled Thyroid dysfunction.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 13, 'thyroid')]
PMC4794442	3/2016	S40-PMC4794442	['Thyroid Stimulating Hormone (Tsh), Cortisol, and Urine protein were within normal limits.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 0, 'thyroid'), ('CHEBI_66524', 'streptokordin', 8, 'stimulating hormone'), ('CHEBI_17855', 'triglyceride', 29, 'TSH'), ('CHEBI_17650', 'cortisol', 35, 'cortisol'), ('UBERON_0001088', 'urine', 49, 'urine')]
PMC4798618	3/2016	S40-PMC4798618	['significant exclusion criteria included Cavity-distorting Intramural fibroids, stage iii or iv endometriosis, Hydrosalpinx, history of previous poor response, recurrent Miscarriage, Adrenal or Thyroid disease, and Thromboembolic disease or disorder.']	N/A	N/A	[('UBERON_0005985', 'coronary vessel', 40, 'cavity'), ('UBERON_3000715', 'heterocoelous', 58, 'intramural'), ('UBERON_0011601', 'gingiva of upper jaw', 110, 'hydrosalpinx'), ('GO_0046660', 'female sex differentiation', 169, 'miscarriage'), ('UBERON_0002369', 'adrenal gland', 182, 'adrenal'), ('UBERON_0002046', 'thyroid gland', 193, 'thyroid'), ('GO_0007596', 'blood coagulation', 214, 'thromboembolic')]
PMC4892913	10/2015	S1-PMC4892913	['at high doses, Perchlorate, Thiocyanate, and Nitrate inhibit Iodide Uptake Into the Thyroid and decrease Thyroid hormone production.']	N/A	N/A	[('CHEBI_49706', 'perchlorate', 15, 'perchlorate'), ('CHEBI_18022', 'thiocyanate', 28, 'thiocyanate'), ('CHEBI_17137', 'hydrogensulfite', 45, 'nitrate'), ('CHEBI_16382', 'iodide', 61, 'iodide'), ('GO_0007624', 'ultradian rhythm', 68, 'uptake into ... thyroid'), ('UBERON_0002046', 'thyroid gland', 84, 'thyroid'), ('GO_0007565', 'female pregnancy', 105, 'thyroid'), ('UBERON_0002046', 'thyroid gland', 105, 'thyroid')]
PMC4892913	10/2015	S4-PMC4892913	['methods:\nSerum Thyroid hormones and anti-Thyroid Antibodies and Urinary Perchlorate, Thiocyanate, Nitrate, and Iodide concentrations were measured in 1,880 Pregnant women from san diego county, california, during 2000–2003, a period when much of the area’s Water supply was contaminated from an industrial plant with Perchlorate at levels near the 2007 california Regulatory standard of 6 μg/l.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 9, 'Serum'), ('UBERON_0002046', 'thyroid gland', 15, 'thyroid'), ('UBERON_0002046', 'thyroid gland', 41, 'thyroid'), ('GO_0042571', 'immunoglobulin complex, circulating', 49, 'antibodies'), ('UBERON_0001088', 'urine', 64, 'urinary'), ('CHEBI_49706', 'perchlorate', 72, 'perchlorate'), ('CHEBI_18022', 'thiocyanate', 85, 'thiocyanate'), ('CHEBI_17137', 'hydrogensulfite', 98, 'nitrate'), ('CHEBI_16382', 'iodide', 111, 'iodide'), ('GO_0007565', 'female pregnancy', 156, 'pregnant'), ('CHEBI_15377', 'water', 257, 'water'), ('CHEBI_49706', 'perchlorate', 317, 'perchlorate'), ('GO_0065007', 'biological regulation', 364, 'regulatory')]
PMC4892913	10/2015	S15-PMC4892913	['at medicinal levels, Perchlorate blocks Iodide uptake into the Thyroid (wyngaarden et al.']	N/A	N/A	[('CHEBI_49706', 'perchlorate', 21, 'perchlorate'), ('CHEBI_16382', 'iodide', 40, 'iodide'), ('UBERON_0002046', 'thyroid gland', 63, 'thyroid')]
PMC4892913	10/2015	S90-PMC4892913	['results\nUrinary Perchlorate and Serum Thyroid hormone concentrations were available on 1,880 women.']	N/A	N/A	[('UBERON_0001088', 'urine', 8, 'Urinary'), ('CHEBI_49706', 'perchlorate', 16, 'perchlorate'), ('UBERON_0001977', 'blood serum', 32, 'serum'), ('UBERON_0002046', 'thyroid gland', 38, 'thyroid')]
PMC4892913	10/2015	S95-PMC4892913	['caption (table-wrap): table 1\n\ndistributions of maternal Urinary analytes and Serum Thyroid hormones.analyte n mean ± sdminimumpercentilemaximum25th50th75thurine Perchlorate (μg/l)1,8808.49 ± 9.860.233.956.509.96177.00urine Thiocyanate (μg/l)1,8801,353 ± 1,553204598981,59016,200urine Nitrate (mg/l)1,87666.5 ± 57.00.732.955.584.3796.0urine Iodide (μg/l)1,818214.9 ± 247.30.877.0154.5270.03,000urine creatinine (mg/dl)1,878131.5± 75.77.973.3120.9175.0472.5serum total t4 (μg/dl)b1,88012.31 ± 1.890.5611.2112.2613.4019.99serum Tsh (μiu/ml)b1,8791.36 ± 0.860.0030.801.201.698.39serum ft4 (ng/dl)b1,8800.86 ± 0.190.110.770.850.935.44tg Antibody (iu/ml)1,8793.11 ± 24.130.000.000.000.60565.90tpo Antibody (iu/ml)1,87612.90 ± 59.730.100.500.801.50704.90urine collection (week)1,8788.6 ± 5.20.15.77.110.042.9serum collection (week)1,88017.1 ± 1.59.116.117.018.026.0urine-Serum difference (weeks)a1,8789.2 ± 3.80.07.09.911.626.7abbreviations: ft4, free thyroxine; t4, total thyroxine; tg, thyroglobulin; tpo, thyroperoxidase; tsh, Thyroid-Stimulating Hormone.aabsolute difference between Urine and Serum collection times.']	N/A	N/A	[('UBERON_0001088', 'urine', 57, 'urinary'), ('UBERON_0001977', 'blood serum', 78, 'serum'), ('CHEBI_9437', 'temoporfin', 84, 'thyroid'), ('UBERON_0002046', 'thyroid gland', 84, 'thyroid'), ('CHEBI_49706', 'perchlorate', 162, 'perchlorate'), ('CHEBI_18022', 'thiocyanate', 224, 'thiocyanate'), ('CHEBI_17137', 'hydrogensulfite', 285, 'nitrate'), ('CHEBI_16382', 'iodide', 341, 'iodide'), ('CHEBI_17855', 'triglyceride', 526, 'TSH'), ('GO_0042571', 'immunoglobulin complex, circulating', 633, 'antibody'), ('GO_0042571', 'immunoglobulin complex, circulating', 692, 'antibody'), ('UBERON_0001977', 'blood serum', 865, 'serum'), ('CHEBI_9437', 'temoporfin', 1024, 'thyroid'), ('PR_000016293', 'protein-glutamine gamma-glutamyltransferase 2', 1024, 'thyroid-stimulating hormone'), ('UBERON_0002046', 'thyroid gland', 1024, 'thyroid'), ('CHEBI_66524', 'streptokordin', 1032, 'stimulating hormone'), ('UBERON_0001088', 'urine', 1081, 'urine'), ('UBERON_0001977', 'blood serum', 1091, 'serum')]
PMC4892913	10/2015	S98-PMC4892913	['the american Thyroid association upper reference range for Tsh in the second Trimester of Pregnancy is 3.0 μiu/ml (garber et al.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 13, 'Thyroid'), ('CHEBI_17855', 'triglyceride', 59, 'TSH'), ('GO_0009294', 'DNA mediated transformation', 77, 'trimester'), ('GO_0007565', 'female pregnancy', 90, 'pregnancy')]
PMC4892913	10/2015	S106-PMC4892913	['caption (table-wrap): table 2\n\nmaternal Thyroid Hormone concentrations stratified by various demographic factors.category n (%)T4 (μg/dl)ft4 (ng/dl)Tsh (μiu/ml)amedianmean ± sd p -valuebmedianmean ± sd p -valuebmedianmean ± sd p -valuebmother’s age (years)< 21435 (23.1)12.4312.50 ± 1.870.870.87 ± 0.141.261.36 ± 0.7721–25563 (29.9)12.3612.45 ± 1.910.860.87 ± 0.231.161.35 ± 0.8826–30414 (22.0)12.2612.38 ± 1.880.840.85 ± 0.241.161.36 ± 0.98> 30468 (24.9)11.9111.90 ± 1.830.830.83 ± 0.131.231.38 ± 0.80 r –0.12< 0.001–0.14< 0.0010.010.78mother’s education (highest grade)< 9509 (27.6)12.4212.57 ± 1.960.840.86 ± 0.301.121.33 ± 0.909–11308 (16.7)12.3112.35 ± 2.080.850.86 ± 0.151.221.41 ± 0.8712568 (30.8)12.2312.22 ± 1.810.850.86 ± 0.131.211.32 ± 0.82> 12460 (24.9)12.0512.07 ± 1.730.850.85 ± 0.121.261.44 ± 0.86 r –0.10< 0.0010.020.310.070.003mother’s weight (lbs)< 121469 (24.9)12.3812.49 ± 1.770.870.89 ± 0.251.151.32 ± 0.85122–145471 (25.1)12.1012.09 ± 1.800.850.86 ± 0.121.171.31 ± 0.82146–171466 (24.8)12.3112.39 ± 1.810.850.86 ± 0.231.231.38 ± 0.87> 171474 (25.2)12.2512.27 ± 2.130.830.83 ± 0.141.271.44 ± 0.90 r –0.010.54–0.14< 0.0010.060.01serum collection (weeks Gestation)< 16467 (24.8)12.4812.56 ± 1.750.880.89 ± 0.141.151.29 ± 0.8617512 (27.2)12.2012.32 ± 1.840.850.86 ± 0.211.251.37 ± 0.7718448 (23.8)12.1512.16 ± 1.820.820.84 ± 0.121.161.36 ± 0.87> 18453 (24.1)12.2512.19 ± 2.110.830.84 ± 0.251.241.43 ± 0.94 r –0.070.004–0.19< 0.0010.040.08tg (iu/ml)≤ 41,719 (91.4)12.2212.25 ± 1.830.850.86 ± 0.201.201.36 ± 0.82> 4161 (8.6)12.9712.97 ± 2.30< 0.0010.830.84 ± 0.130.051.171.43 ± 1.250.16Tpo (iu/ml)≤ 91,715 (91.2)12.2612.33 ± 1.870.850.86 ± 0.201.161.28 ± 0.71> 9165 (8.8)12.2312.10 ± 2.070.470.820.82 ± 0.130.0061.652.21 ± 1.54< 0.001ethnicityhispanic1,303 (69.3)12.3812.47 ± 1.90ref0.850.86 ± 0.21ref1.171.34 ± 0.86refwhite391 (20.8)11.8811.87 ± 1.72< 0.0010.840.84 ± 0.120.171.311.52 ± 0.91< 0.001asian72 (3.8)12.3012.17 ± 2.270.540.840.83 ± 0.140.481.201.23 ± 0.660.53black24 (1.3)11.9211.37 ± 1.840.010.900.90 ± 0.130.101.191.44 ± 0.830.55other90 (4.8)12.0112.32 ± 1.740.160.870.90 ± 0.190.060.941.04 ± 0.69< 0.001mother’s birthplaceusa854 (45.4)12.1012.16 ± 1.81ref0.850.85 ± 0.13ref1.251.42 ± 0.86refmexico889 (47.3)12.3812.45 ± 1.970.0010.840.86 ± 0.240.651.161.32 ± 0.870.002other137 (7.3)12.2812.35 ± 1.790.200.880.90 ± 0.14< 0.0011.131.24 ± 0.730.02abbreviations: ft4, free Thyroxine; r , spearman correlation coefficient; ref, reference category; t4, total thyroxine; tg, thyroglobulin Antibody; tpo, thyroperoxidase Antibody; tsh, Thyroid stimulating hormone.aone subject was missing a Serum Tsh value.bwhen the variables are continuous, p -values are provided for the spearman correlation coefficient between the two continuous variables.']	N/A	N/A	[('CHEBI_60311', 'thyroid hormone', 40, 'thyroid hormone'), ('UBERON_0002046', 'thyroid gland', 40, 'thyroid'), ('PR_000016190', 'trichohyalin-like protein 1', 127, 'T4'), ('CHEBI_17855', 'triglyceride', 148, 'TSH'), ('GO_0007565', 'female pregnancy', 1173, 'gestation'), ('CHEBI_63016', 'nonyl phenoxypolyethoxylethanol', 1600, '16TPO'), ('CHEBI_17842', 'trypanothione', 2400, 'thyroxine'), ('GO_0042571', 'immunoglobulin complex, circulating', 2513, 'antibody'), ('GO_0042571', 'immunoglobulin complex, circulating', 2544, 'antibody'), ('UBERON_0002046', 'thyroid gland', 2559, 'thyroid'), ('UBERON_0001977', 'blood serum', 2614, 'serum'), ('CHEBI_17855', 'triglyceride', 2620, 'TSH')]
PMC4892913	10/2015	S107-PMC4892913	['when variables are ordinal, p -values are provided comparing the mean Thyroid hormone value in each group to a reference group.']	N/A	N/A	[('CHEBI_9437', 'temoporfin', 70, 'thyroid'), ('UBERON_0002046', 'thyroid gland', 70, 'thyroid')]
PMC4892913	10/2015	S115-PMC4892913	['caption (table-wrap): table 3\n\nregression coefficients between maternal log10urine Perchlorate concentrations and Serum Thyroid Hormone concentrations.']	N/A	N/A	[('CHEBI_49706', 'perchlorate', 83, 'perchlorate'), ('UBERON_0001977', 'blood serum', 114, 'serum'), ('CHEBI_60311', 'thyroid hormone', 120, 'thyroid hormone'), ('UBERON_0002046', 'thyroid gland', 120, 'thyroid')]
PMC4892913	10/2015	S116-PMC4892913	['agroup n t4 [βb(95% ci)]ft4 [βb(95% ci)]log10tsh [βb(95% ci)]all subjects1,476–0.70 (–1.06, –0.34)–0.053 (–0.092, –0.013)0.071 (0.008, 0.133)Iodide< 100 μg/l452–0.57 (–1.20, 0.07)–0.022 (–0.100, 0.056)0.034 (–0.081, 0.148)100–300 μg/l698–0.44 (–0.95, 0.08)–0.031 (–0.067, 0.005)0.094 (0.002, 0.189)> 300 μg/l326–1.77 (–2.73, –0.81)–0.172 (–0.305, –0.039)0.089 (–0.058, 0.236)Thiocyanate< 519 μg/l360–0.41 (–1.05, 0.24)–0.034 (–0.074, 0.006)0.039 (–0.092, 0.170)519–1,620 μg/l741–0.74 (–1.27, –0.21)–0.082 (–0.154, –0.010)0.086 (0.005, 0.166)> 1,620 μg/l375–1.28 (–2.04, –0.51)–0.041 (–0.098, 0.016)0.115 (–0.021, 0.252)Nitrate< 36.3 mg/l366–0.20 (–0.88, 0.48)–0.040 (–0.133, 0.054)0.053 (–0.071, 0.178)36.3–81.9 mg/l737–0.72 (–1.32, –0.12)–0.062 (–0.130, 0.006)0.093 (–0.014, 0.200)> 81.9 mg/l369–1.04 (–1.70, –0.38)–0.057 (–0.101, –0.013)0.099 (0.000, 0.199)ethnicityhispanic1,035–0.78 (–1.21, –0.36)–0.073 (–1.124, –0.023)0.037 (–0.032, 0.106)non-hispanic441–0.59 (–1.27, 0.09)–0.002 (–0.054, 0.050)0.184 (0.052, 0.317)sample collectionc≤ 8 weeks apart470–1.05 (–1.73, –0.38)–0.052 (–0.136, 0.033)0.001 (–0.121, 0.122)> 8 weeks apart1,006–0.55 (–0.98, –0.13)–0.050 (–0.092, –0.008)0.107 (0.036, 0.178)anti-Thyroid Antibodiespositived203–1.55 (–2.75, –0.34)–0.093 (–0.159, –0.027)0.153 (–0.060, 0.365)negative1,273–0.52 (–0.89, –0.15)–0.047 (–0.091, –0.002)0.060 (–0.004, 0.123)abbreviations: β, regression coefficient; ft4, free Thyroxine; t4, total thyroxine; Tsh, Thyroid-stimulating Hormone.aonly includes participants with Urinary creatinine concentrations between the 10th and 90th percentiles (i.e., 41–233 mg/dl).badjusted for Urinary creatinine, maternal age, maternal education, ethnicity (hispanic vs. non-hispanic), Gestational age at Serum collection, and Urinary Thiocyanate.cweeks between Urine and Serum sample collection.dincludes participants with thyroperoxidase or thyroglobulin Antibody concentrations above 9 and 4 iu/ml, respectively.']	N/A	N/A	[('CHEBI_5859', 'Icacine', 141, 'Iodide'), ('CHEBI_18022', 'thiocyanate', 375, 'Thiocyanate'), ('CHEBI_17120', 'hexanoate', 619, 'Nitrate'), ('UBERON_0002046', 'thyroid gland', 1208, 'thyroid'), ('GO_0033096', 'amyloplast envelope', 1216, 'antibodiesPositived203'), ('CHEBI_17842', 'trypanothione', 1431, 'thyroxine'), ('CHEBI_17855', 'triglyceride', 1463, 'TSH'), ('CHEBI_9437', 'temoporfin', 1468, 'thyroid'), ('UBERON_0002046', 'thyroid gland', 1468, 'thyroid'), ('CHEBI_33280', 'molecular messenger', 1488, 'hormone'), ('UBERON_0001088', 'urine', 1529, 'urinary'), ('UBERON_0001088', 'urine', 1636, 'urinary'), ('GO_0007565', 'female pregnancy', 1729, 'gestational'), ('UBERON_0001977', 'blood serum', 1748, 'serum'), ('UBERON_0001088', 'urine', 1770, 'urinary'), ('CHEBI_18022', 'thiocyanate', 1778, 'thiocyanate'), ('UBERON_0001088', 'urine', 1805, 'urine'), ('UBERON_0001977', 'blood serum', 1815, 'serum'), ('GO_0042571', 'immunoglobulin complex, circulating', 1900, 'antibody')]
PMC4892913	10/2015	S166-PMC4892913	['the results of this study are based on single assessments of Urinary concentrations of Perchlorate, Iodine, Thiocyanate, Nitrate, and Serum Thyroid hormones separated by an average of 9 weeks.']	N/A	N/A	[('UBERON_0001088', 'urine', 61, 'urinary'), ('CHEBI_49706', 'perchlorate', 87, 'perchlorate'), ('CHEBI_24859', 'iodine atom', 100, 'iodine'), ('CHEBI_18022', 'thiocyanate', 108, 'thiocyanate'), ('CHEBI_17137', 'hydrogensulfite', 121, 'nitrate'), ('UBERON_0001977', 'blood serum', 134, 'serum'), ('UBERON_0002046', 'thyroid gland', 140, 'thyroid')]
PMC4896250	4/2016	S1423-PMC4896250	['further, Serum Antibodies to thyroglobulin (atg) and Thyroid peroxidase (atpo), ana, and total Ige were measured.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 9, 'serum'), ('GO_0042571', 'immunoglobulin complex, circulating', 15, 'antibodies'), ('UBERON_0002046', 'thyroid gland', 53, 'thyroid'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 95, 'IgE')]
PMC4896250	4/2016	S4975-PMC4896250	['laboratory investigations revealed positive anti-Nuclear Antibody in 26% (12/47; none with anti-Thyroid Antibodies), circulating Eosinophilia in 24% (14/59), increased Serum total Ige in 68% (40/59) and low Plasma C3 and/or c4 levels in 30% (16/53).']	N/A	N/A	[('GO_0005634', 'nucleus', 49, 'nuclear'), ('GO_0042571', 'immunoglobulin complex, circulating', 57, 'antibody'), ('UBERON_0002046', 'thyroid gland', 96, 'thyroid'), ('GO_0042571', 'immunoglobulin complex, circulating', 104, 'antibodies'), ('CL_0000771', 'eosinophil', 129, 'eosinophilia'), ('UBERON_0001977', 'blood serum', 168, 'serum'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 180, 'IgE'), ('UBERON_0001969', 'blood plasma', 207, 'plasma'), ('PR_000004904', 'complement C5', 214, 'C3')]
PMC4896250	4/2016	S8444-PMC4896250	['Autoantibodies to Thyroid Tissue and many other Cellular and Cell Surface receptors commonly coexist.']	N/A	N/A	[('GO_0044308', 'axonal spine', 0, 'Autoantibodies'), ('UBERON_0002046', 'thyroid gland', 18, 'thyroid'), ('UBERON_0000479', 'tissue', 26, 'tissue'), ('GO_0005938', 'cell cortex', 48, 'cellular ...'), ('GO_0009986', 'cell surface', 61, 'cell surface')]
PMC4919374	6/2016	S89-PMC4919374	['Thyroid\nAutoimmune Thyroid disease is common in women with t1dm [47].']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 0, 'Thyroid'), ('UBERON_0005445', 'segment of pes', 8, 'Autoimmune'), ('UBERON_0002046', 'thyroid gland', 19, 'thyroid')]
PMC4929134	8/2016	S107-PMC4929134	['these proteins are known to transport or Regulate Insulin-like growth factors, Thyroid hormone, and Lipids/Cholesterol in the Circulatory System.']	N/A	N/A	[('GO_0065007', 'biological regulation', 41, 'regulate'), ('PR_000045358', 'insulin family protein', 50, 'insulin'), ('UBERON_0002046', 'thyroid gland', 79, 'thyroid'), ('CHEBI_18059', 'lipid', 100, 'lipids'), ('CHEBI_16113', 'cholesterol', 107, 'cholesterol'), ('UBERON_0001009', 'circulatory system', 126, 'circulatory system')]
PMC4944244	7/2016	S38-PMC4944244	['the exclusion criteria were mothers with pre-existing type i or type ii diabetes, pre-existing hypertension, pre-existing Parathyroid disease or uncontrolled Thyroid disease, rheumatoid arthritis, Metabolic bone disease, malabsorption, Kidney disease, Liver disease or treatment with Antiepileptic Drugs or Antituberculous.']	N/A	N/A	[('UBERON_0001132', 'parathyroid gland', 122, 'parathyroid'), ('UBERON_0002046', 'thyroid gland', 158, 'thyroid'), ('GO_0008152', 'metabolic process', 197, 'metabolic'), ('UBERON_0002113', 'kidney', 236, 'kidney'), ('UBERON_0002107', 'liver', 252, 'liver'), ('CHEBI_35473', 'tranquilizing drug', 284, 'antiepileptic drugs'), ('CHEBI_35494', 'D-cystine', 307, 'antituberculous')]
PMC4949006	7/2016	S106-PMC4949006	['fetal Thyroid-stimulating hormone is not synthesized until the 10th to 12th week of Gestation, approximately the same time that the fetal Thyroid is capable of concentrating Iodine and synthesizing iodothyronine.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 6, 'thyroid'), ('GO_0007565', 'female pregnancy', 84, 'gestation'), ('UBERON_0002046', 'thyroid gland', 138, 'thyroid'), ('CHEBI_24859', 'iodine atom', 174, 'iodine')]
PMC4949006	7/2016	S110-PMC4949006	['when maternal Iodine Intake is low, maternal Thyroid Hormone Production is low.']	N/A	N/A	[('CHEBI_24859', 'iodine atom', 14, 'iodine'), ('GO_0007631', 'feeding behavior', 21, 'intake'), ('CHEBI_60311', 'thyroid hormone', 45, 'thyroid hormone'), ('GO_0032640', 'tumor necrosis factor production', 45, 'thyroid hormone production'), ('UBERON_0002046', 'thyroid gland', 45, 'thyroid')]
PMC5035678	4/2016	S38-PMC5035678	['those women with known type 1 or 2 diabetes before Pregnancy, a history of hypertension, or untreated Thyroid disorders were not included.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 51, 'pregnancy'), ('UBERON_0002046', 'thyroid gland', 102, 'thyroid')]
PMC5059985	10/2016	S7-PMC5059985	['Genes at the centre of these processes included the Apolipoproteins Apob, Apoa2 and Apoc2, Microsomal Triglyceride Transfer Protein (Mttp), the Clathrin-Endocytosis receptor Cubilin, the transcription factor Retinol Binding Protein 4 (Rbp4) and Transerythrin (Ttr; a Retinol and Thyroid Hormone transporter).']	N/A	N/A	[('SO_0000704', 'gene', 0, 'Genes'), ('CHEBI_39015', 'apolipoprotein', 52, 'apolipoproteins'), ('PR_000004155', 'apolipoprotein E', 68, 'ApoB'), ('PR_000004155', 'apolipoprotein E', 74, 'ApoA2'), ('PR_000004155', 'apolipoprotein E', 84, 'ApoC2'), ('CHEBI_34853', 'Mitobronitol', 91, 'microsomal'), ('PR_000010211', 'protein max', 91, 'microsomal triglyceride transfer protein'), ('CHEBI_17855', 'triglyceride', 102, 'triglyceride'), ('PR_000010911', 'lens fiber major intrinsic protein', 133, 'Mttp'), ('GO_0072583', 'clathrin-dependent endocytosis', 144, 'clathrin-endocytosis'), ('PR_000006022', 'lysosomal protective protein', 174, 'cubilin'), ('CHEBI_26536', 'retinoic acid', 208, 'retinol'), ('PR_000013710', 'Ran-binding protein 10', 208, 'retinol binding protein 4'), ('PR_000013639', 'Ras-related protein Rab-7a', 235, 'Rbp4'), ('PR_000016293', 'protein-glutamine gamma-glutamyltransferase 2', 245, 'transerythrin'), ('PR_000016190', 'trichohyalin-like protein 1', 260, 'Ttr'), ('CHEBI_26536', 'retinoic acid', 267, 'retinol'), ('CHEBI_60311', 'thyroid hormone', 279, 'thyroid hormone'), ('UBERON_0002046', 'thyroid gland', 279, 'thyroid')]
PMC5095257	11/2016	S40-PMC5095257	["concomitant Autoimmune conditions in aad subjectsaad patentsunited kingdom cohort number (%)polish cohort number (%)isolated aad192 (46)60 (27)Autoimmune Thyroid disease167 (40)156 (69.6)\u2003\u2003\u2003\u2003hashimoto thyroiditis132 (32)123 (54.9)\u2003\u2003\u2003\u2003graves' disease35 (8.4)33 (14.7)chronic atrophic gastritis ± pernicious anaemia18 (4.4)27 (12.1)type 1 diabetes25 (6)22 (9.8)celiac disease8 (1.9)3 (1.3)hypergonadotrophic hypogonadism42 (10)15 (6.7)vitiligo15 (3.6)14 (6.3)alopeciano data4 (1.8)rheumatoid arthritis8 (1.9)no data\nthis study was carried out with approval of the leeds east ethics committee (reference number 05/q1206/144) and the ethical committee at poznan university of medical sciences (decision 457/14)."]	N/A	N/A	[('UBERON_0005445', 'segment of pes', 12, 'Autoimmune'), ('UBERON_0005445', 'segment of pes', 143, 'Autoimmune'), ('UBERON_0002046', 'thyroid gland', 154, 'thyroid')]
PMC5118969	11/2016	S46-PMC5118969	['graves’ disease was ruled out with negative Thyroid-stimulating Immunoglobulin and anti-Thyroid peroxidase Antibodies (table 2).']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 44, 'thyroid'), ('GO_0019814', 'immunoglobulin complex', 64, 'immunoglobulin'), ('UBERON_0002046', 'thyroid gland', 88, 'thyroid'), ('GO_0042571', 'immunoglobulin complex, circulating', 107, 'antibodies')]
PMC5118969	11/2016	S53-PMC5118969	['caption (table-wrap): table 1\n\nlaboratory parameters on admission.parametersvalues hemoglobin (g/dl)15.4hematocrit (%)47platelet count (k/μl)127leucocyte count (k/μl)13.6serum Sodium (meq/l)133serum Potassium (meq/l)2.4serum Chloride (meq/l)77serum bicarbonate (meq/l)30bun (mg/dl)43creatinine (mg/dl)1.1serum Glucose (mg/dl)151total protein (g/dl)8.5serum Albumin (g/dl)4.8aspartate transaminase (unit/l)285alanine aminotransferase (unit/l)549alkaline phosphatase (unit/l)97total Bilirubin (mg/dl)6.1direct bilirubin (mg/dl)4.5lactic acid level (mmol/l)2.6urine analysisnegativeblood culturesnegativeurine culturesnegativeurine toxicologycannabinoids\n\ncaption (table-wrap): table 2\n\nCardiac markers and Thyroid panel during the admission.day 1day 1day 2day 2 Troponin T (ng/ml)1.4103.1903.6003.110creatine kinase (μ/l)1107223629711344creatine kinase mb (ng/ml)66.5981tsh (iu/l)<0.07<0.07<0.07<0.07t3 (ng/dl)377298169149t4 (ug/dl)>24.822.8free Thyroxin (ng/dl)7.777.743.722.89\n\ntreatment\nshe was started on Dexamethasone and loaded with Iodine to achieve euthyroid state.']	N/A	N/A	[('CHEBI_52632', 'potassium-39 atom', 176, 'sodium'), ('CHEBI_22314', 'alkali metal atom', 199, 'potassium'), ('CHEBI_17996', 'chloride', 225, 'chloride'), ('CHEBI_17234', 'glucose', 310, 'glucose'), ('PR_000005908', 'alpha-crystallin B chain', 357, 'albumin'), ('CHEBI_16990', 'bilirubin IXalpha', 481, 'bilirubin'), ('UBERON_0000948', 'heart', 684, 'Cardiac'), ('UBERON_0002046', 'thyroid gland', 704, 'thyroid'), ('CHEBI_80935', 'Plocamene C', 760, 'Troponin T'), ('PR_000016649', 'transcription intermediary factor 1-alpha', 760, 'Troponin T'), ('CHEBI_71941', 'tolmetin', 944, 'thyroxin'), ('CHEBI_41879', 'dexamethasone', 1007, 'dexamethasone'), ('CHEBI_24859', 'iodine atom', 1037, 'iodine')]
PMC5118969	11/2016	S73-PMC5118969	['gtt is characterized by an elevated Serum Thyroid Hormone level and low or undetectable Serum Tsh level in the absence of Tsh receptor Antibody.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 36, 'serum'), ('CHEBI_60311', 'thyroid hormone', 42, 'thyroid hormone'), ('UBERON_0002046', 'thyroid gland', 42, 'thyroid'), ('UBERON_0001977', 'blood serum', 88, 'serum'), ('CHEBI_17855', 'triglyceride', 94, 'TSH'), ('PR_000016711', 'TSC22 domain family protein 1', 122, 'TSH'), ('GO_0042571', 'immunoglobulin complex, circulating', 135, 'antibody')]
PMC5121137	11/2016	S4-PMC5121137	['they are confused clinically by surgeons in cases of Head and Neck masses in children as ranulas, Dermoid and Thyroglossal cysts, and lymphangioma.']	N/A	N/A	[('UBERON_0006378', 'strand of vibrissa hair', 53, 'head ...'), ('UBERON_0000974', 'neck', 62, 'neck'), ('UBERON_0007376', 'outer epithelium', 98, 'dermoid'), ('UBERON_0002046', 'thyroid gland', 110, 'thyroglossal')]
PMC5134748	11/2017	S27-PMC5134748	['no history of chronic diseases, such as diabetes, hypertension, Cardiovascular diseases and Thyroid dysfunction, iv.']	N/A	N/A	[('UBERON_0004535', 'cardiovascular system', 64, 'cardiovascular'), ('UBERON_0002046', 'thyroid gland', 92, 'thyroid')]
PMC5153572	11/2016	S12-PMC5153572	['the fetal Thyroid Gland begins concentrating Iodine and synthesizing ths after months of Gestation.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 10, 'thyroid gland'), ('CHEBI_24859', 'iodine atom', 45, 'iodine'), ('GO_0007565', 'female pregnancy', 89, 'gestation')]
PMC5153572	11/2016	S19-PMC5153572	['there is also an Estrogen-mediated increase in circulating levels of Thyroid-Binding Globulin (Tbg) during Pregnancy by 2-3 times in Serum tbg concentrations.']	N/A	N/A	[('CHEBI_50114', 'estrogen', 17, 'estrogen'), ('PR_000016293', 'protein-glutamine gamma-glutamyltransferase 2', 69, 'thyroid-binding globulin'), ('UBERON_0002046', 'thyroid gland', 69, 'thyroid'), ('PR_000016131', 'TANK-binding kinase 1-binding protein 1', 95, 'TBG'), ('GO_0007565', 'female pregnancy', 107, 'pregnancy'), ('UBERON_0001977', 'blood serum', 133, 'serum')]
PMC5153572	11/2016	S29-PMC5153572	['thyroid stimulation in response to the thyrotropic activity of Hcg overrides the normal action of the Hypothalamic Pituitary Thyroid feedback system.']	N/A	N/A	[('CHEBI_17883', 'hydrogen chloride', 63, 'HCG'), ('UBERON_0002589', 'lateral corticospinal tract', 102, 'hypothalamic pituitary'), ('UBERON_0002046', 'thyroid gland', 125, 'thyroid')]
PMC5153572	11/2016	S31-PMC5153572	['closure to the end of the First Trimester of Pregnancy in Humans, when Hcg levels reaches at peak, a substantial fraction of the Thyroid-stimulating activity is from hcg.']	N/A	N/A	[('GO_0042733', 'embryonic digit morphogenesis', 26, 'first trimester'), ('GO_0007565', 'female pregnancy', 45, 'pregnancy'), ('NCBITaxon_9606', 'Homo sapiens', 58, 'humans'), ('CHEBI_17883', 'hydrogen chloride', 71, 'HCG'), ('UBERON_0002046', 'thyroid gland', 129, 'thyroid')]
PMC5153572	11/2016	S56-PMC5153572	['Autoantibodies that react with the Orbital Muscle Of the Eye and Fibroblasts of skin are also produced and initiate the extra Thyroidal manifestations of gd (22,23).']	N/A	N/A	[('GO_0044308', 'axonal spine', 0, 'Autoantibodies'), ('UBERON_0006318', 'orbitalis muscle', 35, 'orbital muscle of ... eye'), ('CL_0000057', 'fibroblast', 65, 'fibroblasts'), ('UBERON_0002046', 'thyroid gland', 126, 'thyroidal')]
PMC5153572	11/2016	S59-PMC5153572	['trophoblastic disease: it is resulted from the production of Thyroid stimulators other than tsh.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 61, 'thyroid')]
PMC5153572	11/2016	S63-PMC5153572	['Hcg stimulates the normal maternal Thyroid via tsh receptor to synthesize and Secrete th (29).']	N/A	N/A	[('CHEBI_17883', 'hydrogen chloride', 0, 'HCG'), ('UBERON_0002046', 'thyroid gland', 35, 'thyroid'), ('GO_0046903', 'secretion', 78, 'secrete')]
PMC5153572	11/2016	S77-PMC5153572	['hyperthyroidism from Thyroidgland autonomy: toxic adenoma, as an autonomous Thyroid nodule, is a discrete Thyroid mass whose function is independent or normal Pituitary Control.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 21, 'thyroidgland'), ('UBERON_0002046', 'thyroid gland', 76, 'thyroid'), ('UBERON_0002046', 'thyroid gland', 106, 'thyroid'), ('UBERON_0002109', 'pair of nares', 159, 'pituitary'), ('GO_0065007', 'biological regulation', 169, 'control')]
PMC5153572	11/2016	S84-PMC5153572	['when the situation for excessive Production Of Th subsides, tsh secretion decreases and the Thyroid Gland returns to normal size.']	N/A	N/A	[('GO_0008283', 'cell proliferation', 33, 'production of TH'), ('UBERON_0002046', 'thyroid gland', 92, 'thyroid gland')]
PMC5153572	11/2016	S89-PMC5153572	['if it is still present, Thyroid function testing will show elevated th levels and a suppressed tsh level.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 24, 'thyroid')]
PMC5153572	11/2016	S91-PMC5153572	['then, because the Thyroid has tired its store of hormone, hypothyroidism will develop.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 18, 'thyroid')]
PMC5153572	11/2016	S94-PMC5153572	['the distinguishing feature is that in patients with gd, the Thyroid actively produces hormone and so takes up Radioiodine at 3-5 times the normal rate.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 60, 'thyroid'), ('CHEBI_29270', 'peroxynitrate', 110, 'radioiodine')]
PMC5153572	11/2016	S101-PMC5153572	['in most of these cases there was a previous diagnosis of Thyroid malignancy (21).']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 57, 'thyroid')]
PMC5153572	11/2016	S138-PMC5153572	['the disease is characterized by the presence of high affinity and concentrations of Serum Thyroid Antibody.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 84, 'serum'), ('UBERON_0002046', 'thyroid gland', 90, 'thyroid'), ('GO_0042571', 'immunoglobulin complex, circulating', 98, 'antibody')]
PMC5153572	11/2016	S151-PMC5153572	['Iatrogenic hypothyroidism: Iatrogenic hypothyroidism is resulted from Thyroid surgery, exposure of the Thyroid to external radiation for Neck carcinomas or from rai to treat gd.']	N/A	N/A	[('GO_0001734', 'mRNA (N6-adenosine)-methyltransferase activity', 0, 'Iatrogenic'), ('GO_0001734', 'mRNA (N6-adenosine)-methyltransferase activity', 27, 'Iatrogenic'), ('UBERON_0002046', 'thyroid gland', 70, 'thyroid'), ('UBERON_0002046', 'thyroid gland', 103, 'thyroid'), ('UBERON_0000974', 'neck', 137, 'neck')]
PMC5153572	11/2016	S182-PMC5153572	['understanding the normal physiological Adaptation Of the Pituitary-Thyroidal Axis in Pregnancy enables us to manage cases of Thyroid dysfunction.']	N/A	N/A	[('GO_0051866', 'general adaptation syndrome', 39, 'adaptation of ... axis'), ('UBERON_0002109', 'pair of nares', 57, 'pituitary'), ('UBERON_0002046', 'thyroid gland', 67, 'thyroidal'), ('GO_0007565', 'female pregnancy', 85, 'pregnancy'), ('UBERON_0002046', 'thyroid gland', 125, 'thyroid')]
PMC5295525	6/2015	S22-PMC5295525	['the rest of her laboratory findings, including Coagulation profile and Thyroid stimulating hormone (tsh), were unremarkable.']	N/A	N/A	[('GO_0050817', 'coagulation', 47, 'coagulation'), ('UBERON_0002046', 'thyroid gland', 71, 'thyroid')]
PMC5331611	2/2017	S27-PMC5331611	['in each health care center, on the first visit and at the time of screening for congenital hypothyroidism (within 3–5 days Postpartum), 20 Lactating mothers and their infants were enrolled for participation in this study, if they met the following inclusion criteria: healthy mothers and their infants had no history of Thyroid disorders, were not currently using Iodine containing Supplements and Disinfectants, had had a singleton Birth and intended to exclusively Breast Feed; infants were Born full-term (Gestational age, 37–42 weeks) with an age of 3–5 days and a normal Birth weight (2500–4200 g), and at that point in time (3–5 days),had normal Serum thyrotropin in the neonatal screening program.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 123, 'postpartum'), ('GO_0007594', 'puparial adhesion', 139, 'lactating'), ('UBERON_0002046', 'thyroid gland', 320, 'thyroid'), ('CHEBI_24859', 'iodine atom', 364, 'iodine'), ('CHEBI_33341', 'titanium atom', 382, 'supplements'), ('CHEBI_48108', 'phosphono group', 398, 'disinfectants'), ('GO_0007567', 'parturition', 433, 'birth'), ('UBERON_0000310', 'breast', 467, 'breast'), ('GO_0007631', 'feeding behavior', 474, 'feed'), ('GO_0007567', 'parturition', 493, 'born'), ('GO_0007565', 'female pregnancy', 509, 'gestational'), ('GO_0007567', 'parturition', 576, 'birth'), ('UBERON_0001977', 'blood serum', 652, 'serum')]
PMC5332195	8/2016	S45-PMC5332195	['eligible mothers had to Speak english, be ≥ 18 years of age, and have no history of Gestational diabetes, Thyroid dysfunction, or other endocrine disorders.']	N/A	N/A	[('GO_0008380', 'RNA splicing', 24, 'speak'), ('GO_0007565', 'female pregnancy', 84, 'gestational'), ('UBERON_0002046', 'thyroid gland', 106, 'thyroid')]
PMC5337401	12/2016	S6-PMC5337401	['women with Thyroid Antibodies were excluded; data and samples were available for 191 women.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 11, 'thyroid'), ('GO_0042571', 'immunoglobulin complex, circulating', 19, 'antibodies')]
PMC5337401	12/2016	S20-PMC5337401	['in Iodine deficiency, high tg concentration results from tsh stimulation of the Thyroid, leading to Thyroid enlargement (9).']	N/A	N/A	[('CHEBI_24859', 'iodine atom', 3, 'iodine'), ('UBERON_0002046', 'thyroid gland', 80, 'thyroid'), ('UBERON_0002046', 'thyroid gland', 100, 'thyroid')]
PMC5337401	12/2016	S31-PMC5337401	['relevant exclusion criteria were current smoking, being on Thyroid medication, and taking a Selenium-containing supplement.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 59, 'thyroid'), ('CHEBI_27568', 'selenium atom', 92, 'selenium')]
PMC5337401	12/2016	S40-PMC5337401	['Tsh, free T4 (ft4), and Thyroid peroxidase Antibodies (tpoab) were measured in Serum samples using a modular analytics e170 analyzer (roche diagnostics, mannheim, germany) at the department of clinical chemistry, máxima medical center (veldhoven, the netherlands).']	N/A	N/A	[('CHEBI_17855', 'triglyceride', 0, 'TSH'), ('CHEBI_37972', 'phosphorus-32 atom', 10, 'T4'), ('UBERON_0002046', 'thyroid gland', 24, 'thyroid'), ('GO_0042571', 'immunoglobulin complex, circulating', 43, 'antibodies'), ('UBERON_0001977', 'blood serum', 79, 'serum')]
PMC5337401	12/2016	S44-PMC5337401	['women were defined as Thyroid-Antibody positive if they were positive for tpoab and/or tgab.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 22, 'thyroid'), ('GO_0042571', 'immunoglobulin complex, circulating', 30, 'antibody')]
PMC5337401	12/2016	S47-PMC5337401	['trimester-specific reference ranges for tsh and ft4 derived from women without Thyroid auto-immunity from an Iodine-sufficient region were therefore used (17).']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 79, 'thyroid'), ('CHEBI_24859', 'iodine atom', 109, 'iodine')]
PMC5357333	3/2017	S47-PMC5357333	['her medical history was negative for hypertension and diabetes, and negative for Thyroid, Heart, Lung, or Kidney disease.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 81, 'thyroid'), ('UBERON_0000948', 'heart', 90, 'heart'), ('UBERON_0002048', 'lung', 97, 'lung'), ('UBERON_0002113', 'kidney', 106, 'kidney')]
PMC5472316	6/2017	S107-PMC5472316	['the following parameters for Trabecular Bone (Epiphysis and Metaphysis) were examined: Trabecular thickness (Tb.Th), Trabecular separation (Tb.Sp; defined as the distance between the edges of adjacent Trabeculae, measured directly), and Trabecular number (tb.n) [26,38,39].']	N/A	N/A	[('UBERON_0002483', 'trabecular bone tissue', 29, 'trabecular bone'), ('UBERON_0001437', 'epiphysis', 46, 'epiphysis'), ('UBERON_0001438', 'metaphysis', 60, 'metaphysis'), ('UBERON_0002363', 'dura mater', 87, 'trabecular'), ('UBERON_0002185', 'bronchus', 109, 'Tb'), ('UBERON_0002046', 'thyroid gland', 112, 'Th'), ('UBERON_0002363', 'dura mater', 117, 'trabecular'), ('UBERON_0002185', 'bronchus', 140, 'Tb'), ('UBERON_0002240', 'spinal cord', 143, 'Sp'), ('UBERON_0000440', 'trabecula', 201, 'trabeculae'), ('UBERON_0002363', 'dura mater', 237, 'trabecular')]
PMC5543438	8/2017	S17-PMC5543438	['the northern Territory (nt) covers 1.3 million square kilometres, and 29.6% of the population of 245,100 are aboriginal People, of whom 80% live outside the major city.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 13, 'Territory'), ('NCBITaxon_10088', 'Mus <genus>', 120, 'people')]
PMC5793328	1/2018	S213-PMC5793328	['another use of Iodine databases is in the treatment of Thyroid disease.']	N/A	N/A	[('CHEBI_24859', 'iodine atom', 15, 'iodine'), ('UBERON_0002046', 'thyroid gland', 55, 'thyroid')]
PMC5793328	1/2018	S214-PMC5793328	['patients undergoing radioablation treatment for Thyroid cancer are prescribed a several-week course of a low Iodine diet, in order to enhance uptake of radioactive Iodine [122,123].']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 48, 'thyroid'), ('CHEBI_24859', 'iodine atom', 109, 'iodine'), ('CHEBI_24859', 'iodine atom', 164, 'iodine')]
PMC5958072	5/2018	S35-PMC5958072	['health information consists of various types of reports including: radiographical evaluations, Eyes, soft Tissues (e.g., Thyroid), other evaluations (e.g., temperament tests) and dna test results (for known Genetic diseases that afflict certain breeds).']	N/A	N/A	[('UBERON_0000970', 'eye', 95, 'eyes'), ('UBERON_0000479', 'tissue', 106, 'tissues'), ('UBERON_0002046', 'thyroid gland', 121, 'thyroid'), ('SO_0000704', 'gene', 207, 'genetic')]
PMC6056931	7/2018	S211-PMC6056931	['thyroid hormones (Thyroid stimulating hormone, thyroglobulin, total thyroxine) will be determined in whole Blood spots by using electrochemiluminescence immunoassays.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 18, 'thyroid'), ('UBERON_0000178', 'blood', 107, 'blood')]
